Skip to content
MarketHOT
中文
← Latest news

Suzano S.A. (0000909327) (Filer)

SEC · EDGAR 财务披露 · November 5, 2026 at 4:37 PM ET

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2026.

Commission File Number 001-38755

Suzano S.A.
(Exact name of registrant as specified in its charter)

SUZANO INC.
(Translation of Registrant’s Name into English)

Av. Professor Magalhaes Neto, 1,752
10th Floor, Rooms 1010 and 1011
Salvador, Brazil 41 810-012
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☑    Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐


INCORPORATION BY REFERENCE

This report is incorporated by reference in our registration statements on Form F-3 filed with the U.S. Securities and Exchange Commission on April 30, 2025 (File No. 333-286881, 333-286881-01 and 333-286881-02), and shall be deemed to be a part thereof from the date on which this report is furnished to the SEC, to the extent not superseded by documents or reports subsequently filed or furnished.


Suzano S.A.

Capturar.jpg

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

INDEX

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

1

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

2

CONSOLIDATED BALANCE SHEET

3

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

5

CONSOLIDATED STATEMENTS OF CASH FLOW

6

1 COMPANY’S OPERATIONS

8

2 BASIS OF PREPARATION AND PRESENTATION OF FINANCIAL INFORMATION

15

3 SUMMARY OF MATERIAL ACCOUNTING POLICIES

16

4 FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT

17

5 SEGMENT INFORMATION

27

6 NET SALES

30

7 INCOME (EXPENSES) BY NATURE

31

8 NET FINANCIAL RESULT

32

9 CASH AND CASH EQUIVALENTS

32

10 MARKETABLE SECURITIES

33

11 TRADE ACCOUNTS RECEIVABLE

33

12 INVENTORIES

35

13 RECOVERABLE TAXES

36

14 ADVANCES TO SUPPLIERS

36

15 RELATED PARTIES

37

16 INCOME AND SOCIAL CONTRIBUTION TAXES

39

17 BIOLOGICAL ASSETS

45

18 INVESTMENTS

46

19 PROPERTY, PLANT AND EQUIPMENT    

48

20 INTANGIBLE

49

21 TRADE ACCOUNTS PAYABLE

50

22 LOANS, FINANCING AND DEBENTURES

52

23 LEASES

55

24 PROVISION FOR JUDICIAL LIABILITIES

56

25 EMPLOYEE BENEFIT PLANS

58

26 SHARE-BASED COMPENSATION PLAN

59

27 SHAREHOLDERS’ EQUITY

60

28 EARNINGS PER SHARE

61

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

Third quarterNine months YTD
Note09/30/202609/30/202509/30/202609/30/2025
NET SALES

6

16,515,544 

12,153,145 

39,074,093 

37,001,961 

Cost of sales

7

(12,597,241)

(8,453,761)

(29,166,282)

(24,791,052)

GROSS PROFIT

3,918,303 

3,699,384 

9,907,811 

12,210,909 

OPERATING (EXPENSES) INCOME

Selling

7

(1,206,435)

(849,961)

(2,771,626)

(2,443,093)

General and administrative

7

(1,146,358)

(664,953)

(2,385,784)

(1,985,970)

Loss from associates and joint ventures

18

(7,976)

(79,268)

(33,572)

(268,350)

Other operating (expenses) income, net

7

45,861 

(135,667)

1,450,333 

(409,782)

OPERATING PROFIT BEFORE NET FINANCIAL INCOME

1,603,395 

1,969,535 

6,167,162 

7,103,714 

NET FINANCIAL INCOME (EXPENSES)

8

Financial expenses

(1,842,761)

(1,823,415)

(5,353,673)

(5,069,939)

Financial income

509,516 

462,095 

1,519,283 

1,284,207 

Derivative financial instruments, net

2,499,863 

1,079,117 

6,501,811 

7,431,622 

Monetary and exchange variations, net

(20,504)

1,333,984 

3,084,709 

9,527,069 

NET INCOME BEFORE TAXES

2,749,509 

3,021,316 

11,919,292 

20,276,673 

Income and social contribution taxes

Current

16

(263,887)

(161,908)

(289,780)

(472,442)

Deferred

16

(401,667)

(898,021)

(3,426,100)

(6,482,713)

NET INCOME FOR THE PERIOD

2,083,955 

1,961,387 

8,203,412 

13,321,518 

Attributable to

Controlling shareholders’

2,103,937 

1,953,516 

8,209,902 

13,298,971 

Non-controlling interest

(19,982)

7,871 

(6,490)

22,547 

Earnings per share

Basic

28.1

1.70815 

1.58063 

6.65219 

10.75126 

Diluted

28.2

1.70416 

1.57671 

6.63691 

10.72459 

The accompanying notes are an integral part of this unaudited condensed consolidated interim financial information.

1

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

Third quarterNine months YTD
09/30/202609/30/202509/30/202609/30/2025

Net income for the period

2,083,955 

1,961,387 

8,203,412 

13,321,518 

Other comprehensive income (loss)

Fair value investments in equity measured at fair value through other comprehensive income (1)

(76,190)

48,856 

(47,115)

(148,284)

Deferred tax relating to fair value of investments

(4)

413 

819 

1,068 

Actuarial gain (loss) on post-employment plans of subsidiaries

6,778 

6,778 

Tax effect of the actuarial (gain) loss

(1,763)

(1,763)

Items with no subsequent effect on income (loss)

(71,179)

49,269 

(41,281)

(147,216)

Exchange rate variations on conversion of financial information of the subsidiaries abroad (2)

(42,079)

(33,755)

(174,560)

(139,559)

Realization of exchange variation on investments abroad

(15,636)

Cash flow hedge

12,882 

12,882 

Tax effect on cash flow hedge

(7,588)

(7,588)

Items with subsequent effect on income (loss)

(36,785)

(33,755)

(169,266)

(155,195)

Total comprehensive income

1,975,991 

1,976,901 

7,992,865 

13,019,107 

Attributable to

Controlling shareholders’

1,990,074 

1,969,030 

7,993,456 

12,996,560 

Non-controlling interest

(14,083)

7,871 

(591)

22,547 

(1) Includes the fair value arising from the measurement of Lenzing Aktiengesellschaft. For the three-month period ended September 30, 2026, the fair value effect amounted to R$(76,202) (R$50,072 for three-month period ended September 30, 2025). As of September 30, 2026 the fair value effect amounted to R$(44,706) (R$(145,142) as of September 30, 2025).

(2) Includes the amounts related to Suzano Packaging LLC, Lenzing Aktiengesellschaft, and Arbex.

The accompanying notes are an integral part of this unaudited condensed consolidated interim financial information.

2

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

CONSOLIDATED BALANCE SHEET

Note09/30/202612/31/2025

ASSETS

CURRENT

Cash and cash equivalents

9

13,406,218 

15,179,753 

Marketable securities

10

7,781,720 

9,932,774 

Trade accounts receivable

11

8,469,460 

6,560,607 

Inventories

12

10,825,515 

8,155,847 

Recoverable taxes

13

832,163 

887,085 

Recoverable income taxes

13

1,172,183 

659,202 

Derivative financial instruments

4.5

4,108,590 

1,556,978 

Advances to suppliers

14

121,221 

76,818 

Other assets

1,492,531 

858,005 

Total current assets

48,209,601 

43,867,069 

NON-CURRENT

Marketable securities

10

370,135 

319,680 

Recoverable taxes

13

814,204 

945,699 

Deferred taxes

16

946,252 

1,504,014 

Derivative financial instruments

4.5

9,047,545 

8,014,683 

Advances to suppliers

14

3,294,943 

2,788,262 

Judicial deposits

414,426 

418,301 

Call option

4.1.2

803,040 

Other assets

438,826 

187,102 

Biological assets

17

27,490,120 

26,097,164 

Investments

18

1,002,311 

1,194,877 

Property, plant and equipment

19

74,971,248 

64,296,187 

Right of use

23.1

5,588,855 

5,331,789 

Intangible

20

17,194,958 

12,970,692 

Total non-current assets

142,376,863 

124,068,450 

TOTAL ASSETS

190,586,464 

167,935,519 

The accompanying notes are an integral part of this unaudited condensed consolidated interim financial information.

3

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

CONSOLIDATED BALANCE SHEET

Note09/30/202612/31/2025

LIABILITIES

CURRENT

Trade accounts payable

21

8,728,141 

5,141,386 

Loans, financing and debentures

22

4,639,876 

3,004,905 

Lease liabilities

23

971,565 

857,810 

Derivative financial instruments

4.5

1,192,092 

1,205,029 

Taxes payable

391,875 

240,010 

Income taxes payable

380,075 

218,238 

Payroll and charges

1,497,065 

1,132,713 

Dividends payable

7,351 

1,393,121 

Other liabilities

1,206,374 

579,659 

Total current liabilities

19,014,414 

13,772,871 

NON-CURRENT

Loans, financing and debentures

22

93,202,971 

91,796,352 

Lease liabilities

23

6,155,682 

6,072,080 

Derivative financial instruments

4.5

6,335,857 

8,136,320 

Taxes payable

49,365 

Provision for judicial liabilities

24

2,753,748 

2,801,738 

Employee benefit plans

25

885,437 

741,143 

Deferred taxes

16

3,922,347 

Share-based compensation plans

26

350,943 

332,322 

Advances from customers

Other liabilities

470,175 

330,520 

Total non-current liabilities

114,126,525 

110,210,475 

TOTAL LIABILITIES

133,140,939 

123,983,346 

SHAREHOLDERS’ EQUITY

27

Share capital

24,250,120 

24,235,546 

Capital reserves

81,660 

80,742 

Treasury shares

(1,690,481)

(1,511,146)

Profit reserves

20,103,660 

20,118,234 

Accumulated other comprehensive income

600,709 

888,669 

Retained earnings

8,282,185 

Controlling shareholders'

51,627,853 

43,812,045 

Non-controlling interest

5,817,672 

140,128 

Total equity

57,445,525 

43,952,173 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

190,586,464 

167,935,519 

The accompanying notes are an integral part of this unaudited condensed consolidated interim financial information.

4

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

NoteShare
Capital
Capital reservesTreasury sharesProfit reservesAccumulated other comprehensive incomeRetained earningsTotal controlling shareholders' equityNon-controlling interestTotal consolidated shareholders' equity
Balances at December 31, 2024

19,235,546 

60,226 

(1,339,197)

12,978,898 

1,348,796 

32,284,269 

131,306 

32,415,575 

Net income for the period

13,298,971 

13,298,971 

22,547 

13,321,518 

Other comprehensive loss

(302,411)

(302,411)

(302,411)

Stock options granted

26.2

34,081 

34,081 

34,081 

Stock options exercised

26.2

(25,126)

19,969 

(5,157)

(5,157)

Share repurchase

27.2

(191,918)

(191,918)

(191,918)

Unclaimed dividends forfeited

567 

567 

567 

Additional proposed dividend

(9,800)

(9,800)

Transactions with non-controlling interests

(4,030)

(4,030)

Realization of deemed cost, net of taxes

(101,424)

101,424 

Balances at September 30, 2025

19,235,546 

69,181 

(1,511,146)

12,978,898 

944,961 

13,400,962 

45,118,402 

140,023 

45,258,425 

Balances at December 31, 2025

24,235,546 

80,742 

(1,511,146)

20,118,234 

888,669 

43,812,045 

140,128 

43,952,173 

Net income for the period

8,209,902 

8,209,902 

(6,490)

8,203,412 

Other comprehensive loss

(216,446)

(216,446)

5,899 

(210,547)

Stock options granted

26.2

27,949 

27,949 

27,949 

Stock options exercised

26.2

(27,031)

19,110 

(7,921)

(7,921)

Share repurchase

27.2

(198,445)

(198,445)

(198,445)

Unclaimed dividends forfeited

769 

769 

769 

Capital increase

27.1

14,574 

(14,574)

Transactions with non-controlling interests

1.2.1

5,678,135 

5,678,135 

Realization of deemed cost, net of taxes

(71,514)

71,514 

Balances at September 30, 2026

24,250,120 

81,660 

(1,690,481)

20,103,660 

600,709 

8,282,185 

51,627,853 

5,817,672 

57,445,525 

The accompanying notes are an integral part of this unaudited condensed consolidated interim financial information.

5

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

CONSOLIDATED STATEMENTS OF CASH FLOW

09/30/202609/30/2025
OPERATING ACTIVITIES
Net income for the period

8,203,412 

13,321,518 

Adjustment to

Depreciation, depletion and amortization

9,383,570 

7,948,316 

Depreciation of right of use

291,280 

277,901 

Interest expense on lease liabilities (Note 8)

333,734 

347,320 

Result from sale and disposal of non-current assets, net (Note 7)

(146,036)

272,228 

Loss from associates and joint ventures (Note 18.3)

33,572 

268,350 

Exchange rate and monetary variations, net (Note 8)

(3,084,709)

(9,527,069)

Interest expenses on financing, loans and debentures (Note 22.3)

4,414,775 

4,399,815 

Capitalized loan costs (Note 8)

(50,725)

(205,409)

Amortization of transaction costs, premium and discounts (Note 8)

117,573 

75,916 

Derivative (gains) loss, net (Note 8)

(6,501,811)

(7,431,622)

Premium expenses on early settlements (Note 8)

204,416 

89,026 

Accrual of interest on marketable securities

(929,622)

(769,940)

Fair value adjustment of biological assets (Note 17)

(1,157,728)

73,248 

Deferred income tax and social contribution (Note 16.2)

3,426,100 

6,482,713 

Interest on actuarial liabilities and cost of current service (Note 25.2)

62,099 

59,466 

Provision for judicial liabilities, net of reversals (Note 24.1)

66,768 

(41,620)

Provision (reversal) for doubtful accounts, net (Note 11.3)

(23,920)

103,502 

Provision for inventory losses, net (Note 12.1)

72,469 

24,031 

Provision for loss of ICMS credits, net (Note 13.1)

29,757 

151,669 

Other

53,691 

65,633 

Decrease (increase) in assets

Trade accounts receivable

373,343 

1,876,639 

Inventories

(20,871)

(730,937)

Recoverable taxes

(362,928)

(334,268)

Other assets

161,063 

(128,619)

Increase (decrease) in liabilities

Trade accounts payable

642,961 

101,422 

Taxes payable

(136,897)

287,155 

Payroll and charges

4,427 

(164,546)

Other liabilities

(92,181)

(201,628)

Cash generated from operations

15,367,582 

16,690,210 

Payment of interest on financing, loans and debentures (Note 22.3)

(4,447,630)

(4,753,232)

Capitalized loan costs paid

50,725 

205,409 

Premium expenses on early settlements

(204,416)

(89,026)

Interest received on marketable securities

825,142 

969,141 

Payment of income taxes

(197,089)

(229,980)

Cash provided by operating activities

11,394,314 

12,792,522 

The accompanying notes are an integral part of this unaudited condensed consolidated interim financial information.

6

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

09/30/202609/30/2025
INVESTING ACTIVITIES

Additions to property, plant and equipment (Note 19)

(2,239,468)

(3,424,570)

Additions to intangible (Note 20)

(452,371)

(59,574)

Additions to biological assets (Note 17)

(5,508,253)

(6,281,750)

Proceeds from sales of property, plant and equipment and biological assets

330,882 

114,236 

Capital increase (Note 18.3)

(2,500)

(21,979)

Marketable securities, net

2,214,873 

5,093,946 

Advances for acquisition of wood from operations with development and partnerships

(554,506)

(224,669)

Dividends received

3,854 

8,835 

Acquisition of other investments

(9,392)

Acquisition of subsidiary, net of acquired cash (Note 1.2.1)

(3,844,390)

Call option purchase (Note 1.2.1)

(805,514)

Cash used in investing activities

(10,857,393)

(4,804,917)

FINANCING ACTIVITIES

Proceeds from loans, financing and debentures (Note 22.3)

3,087,472 

22,324,556 

Proceeds from derivative transactions (Note 4.5.3)

1,134,652 

370,789 

Payment of loans, financing and debentures (Note 22.3)

(3,385,149)

(19,600,013)

Payment of leases (Note 23.2)

(1,080,282)

(1,059,908)

Payment of dividends

(1,385,007)

(2,208,158)

Liabilities for assets acquisitions and subsidiaries

(18,415)

(20,668)

Shares repurchased (Note 27.2)

(198,445)

(191,918)

Cash used by financing activities

(1,845,174)

(385,320)

Increase in cash and cash equivalents, net

(1,308,253)

7,602,285 

At the beginning of the period

15,179,753 

9,018,818 

Exchange variation on cash and cash equivalents

(465,282)

(782,237)

At the end of the period

13,406,218 

15,838,866 

Increase in cash and cash equivalents, net

(1,308,253)

7,602,285 

The accompanying notes are an integral part of this unaudited condensed consolidated interim financial information.

7

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

.

1 COMPANY’S OPERATIONS

Suzano S.A. (“Suzano”) and its subsidiaries (collectively the “Company”) is a public company with its headquarters in Brazil, at Professor Magalhães Neto Avenue, No. 1,752 - 10th floor, rooms 1010 and 1011, Pituba District, in the city of Salvador, State of Bahia, and its main business office in the city of São Paulo.

Suzano’s shares are traded on B3 S.A. (“Brasil, Bolsa, Balcão - “B3”), listed in the New Market under the ticker SUZB3, and its American Depositary Receipts (“ADRs”) in a ratio of 1 (one) per common share, Level II, are traded in the New York Stock Exchange (“NYSE”) under the ticker SUZ.

The Company has 37 industrial units, of which 13 are located in Brazil and 24 abroad, operating with a strategic presence in North America, Latin America, Europe, South Africa, Asia, and Oceania.

These units produce hardwood pulp from eucalyptus, coated paper, paperboard, uncoated paper and cut size paper, paper rolls and packages of sanitary paper (consumer goods - tissue) to serve the domestic and foreign markets.

The Company also has 06 technology centers, 04 located in Brazil, 01 in China and 01 in Israel focused on product development and industrial process improvement.

In addition, it has a global logistics structure that supports its commercial and export operations. In Brazil, the Company has 29 distribution centers and 04 ports, strategically located for the distribution of its products. Abroad, the structure consists of approximately 161 distribution centers and terminals, distributed across North America, Central America, South America, Europe, South Africa, Asia and Oceania.

The sale of pulp, paper, and consumer goods products in the international markets is carried out through sales by Suzano, and, primarily, through its subsidiaries and/or representation offices operating on a global scale.

The Company's corporate purpose also includes the cultivation of eucalyptus forests for its own use, operation of port terminals, and holding of interests, as a partner or shareholder, in other companies or enterprises, and the generation and commercialization of electricity produced in the pulp manufacturing process.

The Company is controlled by Suzano Holding S.A., through a voting agreement whereby it holds 48.85% of the common shares of its share capital (48.84% as of December 31, 2025).

This unaudited condensed consolidated interim financial information was authorized by the Board of Directors on November 5, 2026.

8

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

1.1 Equity interests

The Company holds equity interests in the following entities:

% equity interest
Entity/Type of investment Main activityCountryFunctional Currency09/30/202612/31/2025
Consolidated

F&E Tecnologia do Brasil S.A. (Direct)

Biofuel production, except alcohol

Brazil

BRL

100.00

%

100.00

%

Fibria Celulose (USA) Inc. (Direct)

Business office

United States of America

BRL

100.00

%

100.00

%

Fibria Terminal de Celulose de Santos SPE S.A. (Direct)

Port operations

Brazil

BRL

100.00

%

100.00

%

FuturaGene Ltda. (Direct)

Biotechnology research and development

England

BRL

100.00

%

100.00

%

FuturaGene Delaware Inc. (Indirect)

Biotechnology research and development

United States of America

BRL

100.00

%

100.00

%

FuturaGene Israel Ltda. (Indirect)

Biotechnology research and development

Israel

BRL

100.00

%

100.00

%

FuturaGene Inc. (Indirect)

Biotechnology research and development

United States of America

BRL

100.00

%

100.00

%

Maxcel Empreendimentos e Participações S.A. (Direct)

Holding

Brazil

BRL

100.00

%

100.00

%

Itacel - Terminal de Celulose de Itaqui S.A. (Indirect)

Port operations

Brazil

BRL

100.00

%

100.00

%

Mucuri Energética S.A. (Direct)

Power generation and distribution

Brazil

BRL

100.00

%

100.00

%

Paineiras Logística e Transportes Ltda. (Direct)

Road freight transport

Brazil

BRL

100.00

%

100.00

%

Portocel - Terminal Espec. Barra do Riacho S.A. (Direct)

Port operations

Brazil

BRL

51.00

%

51.00

%

Projetos Especiais e Investimentos Ltda. (Direct)

Commercialization of equipment and parts

Brazil

BRL

100.00

%

100.00

%

SFBC Participações Ltda. (Direct)

Packaging production

Brazil

BRL

100.00

%

100.00

%

Suzano Argentina S.A.U (Direct)

Commercialization of paper and computer materials

Argentina

BRL

100.00

%

100.00

%

Suzano Austria GmbH. (Direct)

Business office

Austria

BRL

100.00

%

100.00

%

Suzano Canada Inc. (Direct)

Lignin research and development

Canada

BRL

100.00

%

100.00

%

Suzano Ecuador S.A.S. (Direct)

Business office

Ecuador

BRL

100.00

%

100.00

%

Suzano International Finance B.V. (Direct)

Financial fundraising

Netherlands

BRL

100.00

%

100.00

%

Suzano International Holding B.V. (Direct) (1)

Holding

Netherlands

EUR

100.00

%

100.00

%

FamPro Tissue Holdings B.V. (Arbex) (Indirect) (1)

Holding

Netherlands

EUR

51.00

%

Kimberly-Clark Limited (Indirect) (1)

Industrialization and commercialization of tissue products

United Kingdom

GBP

51.00

%

Kimberly-Clark Europe Limited (Indirect) (1)

Holding, industrialization and comercialization of tissue products

United Kingdom

EUR

51.00

%

FamPro Tissue Finance Co Limited (Indirect) (1)

Financial fundraising

United Kingdom

EUR

51.00

%

FamPro Tissue Argentina S.R.L. (Indirect) (1)

Commercialization of tissue

Argentina

ARS

51.00

%

3-102-947126 S.R.L. (Indirect) (1)

Commercialization of tissue

Costa Rica

CRC

51.00

%

3-102-946801 S.R.L. (Indirect) (1)

Commercialization of tissue products, business office

Costa Rica

CRC

51.00

%

FamPro Tissue El Salvador Ltda. de C.V. (Indirect) (1)

Industrialization and commercialization of tissue products

El Salvador

USD

51.00

%

IFP Guatemala, Comm of Prod Ltda. (Indirect) (1)

Commercialization of tissue products

Guatemala

GTQ

51.00

%

FamPro Tissue Panama S. de R.L. (Indirect) (1)

Commercialization of tissue products

Panama

USD

51.00

%

FamPro Tissue Peru S.R.L. (Indirect) (1)

Industrialization and commercialization of tissue products

Peru

PEN

51.00

%

FamPro Tissue Chile SpA (Indirect) (1)

Commercialization of tissue products

Chile

CLP

51.00

%

Colpapel Tissue S.A.S. (Indirect) (1)

Industrialization and commercialization of tissue products

Colombia

COP

51.00

%

FamPro Tissue Ecuador CIA. LTDA. (Indirect) (1)

Commercialization of tissue products

Ecuador

USD

51.00

%

FamPro Tissue Honduras S.deR.L.de C.V. (Indirect) (1)

Commercialization of tissue products

Honduras

HNL

51.00

%

FamPro Tissue Austria GmbH (Indirect) (1)

Commercialization of tissue products

Austria

EUR

51.00

%

FamPro Tissue Belgium B.V. (Indirect) (1)

Commercialization of tissue products

Belgium

EUR

51.00

%

FamPro Tissue Czech Republic s.r.o. (Indirect) (1)

Commercialization of tissue products

Czechia

EUR

51.00

%

Kimberly-Clark SAS (Indirect) (1)

Industrialization and commercialization of tissue products

France

EUR

51.00

%

FamPro Tissue Germany GmbH (Indirect) (1)

Industrialization and commercialization of tissue products

Germany

EUR

51.00

%

FamPro Tissue Israel (Indirect) (1)

Industrialization and commercialization of tissue products

Israel

ILS

51.00

%

Kimberly-Clark S.R.L. (Indirect) (1)

Industrialization and commercialization of tissue products

Italy

EUR

51.00

%

FamPro Tissue Netherlands B.V. (Indirect) (1)

Commercialization of tissue products

Netherlands

EUR

51.00

%

FamPro Tissue Poland sp. z.o.o. (Indirect) (1)

Commercialization of tissue products, business office

Poland

PLN

51.00

%

9

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

% equity interest
Entity/Type of investment Main activityCountryFunctional Currency09/30/202612/31/2025

FamPro Tissue Portugal, Unipessoal Lda. (Indirect) (1)

Commercialization of tissue products

Portugal

EUR

51.00

%

FamPro Tissue South Africa (Pty) Ltd. (Indirect) (1)

Industrialization and commercialization of tissue products

South Africa

ZAR

51.00

%

FamPro Tissue Spain, S.L.U. (Indirect) (1)

Industrialization and commercialization of tissue products

Spain

EUR

51.00

%

FamPro Tissue Switzerland GmbH (Indirect) (1)

Commercialization of tissue products

Switzerland

CHF

51.00

%

Kimberly-Clark IFP ANZ Pty. Limited (Indirect) (1)

Industrialization and commercialization of tissue products

Australia

AUD

51.00

%

SK IFP Singapore Pte. Ltd. (Indirect) (1)

Commercialization of tissue products

Singapore

SGD

51.00

%

SK IFP (Hong Kong) Limited (Indirect) (1)

Commercialization of tissue products

Hong Kong

HKD

51.00

%

FamPro Tissue Malaysia Sdn. Bhd. (Indirect) (1)

Industrialization and commercialization of tissue products

Malaysia

MYR

51.00

%

JV FamPro Tissue Malaysia Sdn. Bhd. (Indirect) (1)

Commercialization of tissue products, business office

Malaysia

MYR

51.00

%

SK (Shanghai) Paper Technology Co., Ltd. (Indirect) (1)

Commercialization of tissue products

China

CNY

51.00

%

SK Corporation (Indirect) (1)

Industrialization and commercialization of tissue products

Taiwan

TWD

51.00

%

KC Europe Ltd (Taiwan Branch) (Indirect) (1)

Commercialization of tissue products

Taiwan

TWD

51.00

%

Taiwan Scott Paper Company (Indirect) (1)

Industrialization and commercialization of tissue products

Taiwan

TWD

51.00

%

KC Hygiene Prod. Private Ltd. (Indirect) (1)

Commercialization of tissue products

India

INR

51.00

%

P.T. Kimberly-Clark Indonesia (Indirect) (1)

Commercialization of tissue products

Indonesia

IDR

51.00

%

FamPro Tissue Philippines Inc. (Indirect) (1)

Commercialization of tissue products

Philippines

PHP

51.00

%

Kimberly – Clark Thailand Limited (Indirect) (1)

Industrialization and commercialization of tissue products

Thailand

THB

51.00

%

KC Manufacturing (Thailand) Limited (Indirect) (1)

Industrialization and commercialization of tissue products

Thailand

THB

51.00

%

SK (Shanghai) Paper Technology Co., Ltd. (Beijing Branch) (Indirect) (1)

Commercialization of tissue products

China

CNY

51.00

%

SK (Shanghai) Paper Technology Co., Ltd. (Guangzhou Branch) (Indirect) (1)

Commercialization of tissue products

China

CNY

51.00

%

SK (Shanghai) Paper Technology Co., Ltd. (Chengdu Branch) (Indirect) (1)

Commercialization of tissue products

China

CNY

51.00

%

KC IFP ANZ Pty Ltd (New Zealand Branch) (Indirect) (1)

Commercialization of tissue products

New Zealand

NZD

51.00

%

KC Europe Ltd (Puerto Rico Branch) (Indirect) (1)

Commercialization of tissue products

Puerto Rico

USD

51.00

%

KC Europe Ltd (Dominican Republic branch) (Indirect) (1)

Commercialization of tissue products

Dominican Republic

DOP

51.00

%

Arbex Brasil Ltda. (Indirect) (1)

Business office

Brazil

BRL

51.00

%

Suzano International Trade GmbH. (Direct)

Business office

Austria

BRL

100.00

%

100.00

%

Suzano Packaging LLC (Indirect)

Production of coated and uncoated paperboard, used in the production of Liquid Packaging Board and Cupstock

United States of America

USD

100.00

%

100.00

%

Suzano Material Technology Development Ltd. (Direct)

Biotechnology research and development

China

BRL

100.00

%

100.00

%

Suzano Netherlands B.V. (Direct)

Financial fundraising

Netherlands

BRL

100.00

%

100.00

%

Suzano Operações Industriais e Florestais S.A. (Direct)

Industrialization, commercialization and exporting of pulp

Brazil

BRL

100.00

%

100.00

%

Suzano Pulp and Paper America Inc. (Direct)

Business office

United States of America

BRL

100.00

%

100.00

%

Suzano Pulp and Paper Europe S.A. (Direct)

Business office

Switzerland

BRL

100.00

%

100.00

%

Suzano Shanghai Ltda. (Direct)

Business office

China

BRL

100.00

%

100.00

%

Suzano Shanghai Trading Ltda. (Direct) (2)

Business office

China

BRL

100.00

%

Suzano Singapura Pte. Ltda. (Direct)

Business office

Singapore

BRL

100.00

%

100.00

%

Suzano Trading International KFT(Direct)

Business office

Hungary

BRL

100.00

%

100.00

%

Suzano Ventures LLC (Direct)

Corporate venture capital

United States of America

BRL

100.00

%

100.00

%

Joint operation

Veracel Celulose S.A. (Direct)

Industrialization, commercialization and exporting of pulp

Brazil

BRL

50.00

%

50.00

%

Equity

Allotrope Energy Ltd (Indirect)

Research and development of battery technology based on carbon derived from lignin biomass

England

USD

19.72

%

20.00

%

Biomas Serviços Ambientais, Restauração e Carbono S.A. (Direct)

Restoration, conservation and preservation of forests

Brazil

BRL

16.66

%

16.66

%

Muçununga Serviços Ambientais, Restauração e Carbono Ltda. (Indirect)

Restoration, conservation and preservation of forests

Brazil

BRL

8.33

%

8.33

%

Ibema Companhia Brasileira de Papel (Direct)

Industrialization and commercialization of paperboard

Brazil

BRL

49.90

%

49.90

%

10

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

% equity interest
Entity/Type of investment Main activityCountryFunctional Currency09/30/202612/31/2025

Simplifyber, Inc. (Indirect)

Production of consumer goods through the transformation of cellulose-based liquids

United States of America

USD

15.52

%

14.20

%

Spinnova Plc. (Direct) (“Spinnova”)

Research of sustainable raw materials for the textile industry

Finland

EUR

18.75

%

18.76

%

Woodspin Oy (Direct/Indirect) (“Woodspin”) (3)

Development and production of cellulose-based fibers, yarns and textile filaments

Finland

EUR

18.75

%

18.76

%

Spinnova Refining Oy (Indirect) (3)

Industrialization and commercialization of cellulose, microfiber cellulose and paper

Finland

EUR

18.75

%

18.76

%

Fair value through other comprehensive income

Bem Agro Integração e Desenvolvimento S.A. (Indirect)

Software solutions based on artificial intelligence and computer vision for agribusiness

Brazil

BRL

4.58

%

5.82

%

Celluforce Inc. (Direct)

Nanocrystalline pulp research and development

Canada

CAD

8.28

%

8.28

%

Lenzing Aktiengesellschaft (Indirect)

Production of wood-based cellulose fibers

Austria

EUR

15.00

%

15.00

%

Nfinite Nanotechnology Inc. (Indirect)

Research and development of smart nanocoatings

Canada

USD

5.40

%

4.90

%

(1)On July 1, 2026, the Company completed the acquisition of Arbex, as further detailed in Note 1.2.1. The other indirect entities listed subsequently, which came to present a 51% ownership interest in the quarter ended September 30, 2026, refer to the subsidiaries consolidated as a result of this transaction.

(2)On June 29, 2026, the Company completed the liquidation of Suzano Shanghai Trading Ltd.

(3)On October 3, 2025, the transaction with Spinnova Plc was completed, involving the transfer of the Company’s interest in Woodspin Oy and Suzano Finland Oy. Following the transaction, Suzano Finland Oy was renamed Spinnova Refining Oy, and Spinnova became the sole owner (100%) of both entities. The Company, in turn, retained an indirect interest in these companies.

1.2 Major events in the period

1.2.1 Acquisition of an interest in a global Consumer Goods (tissue) business

On July 1, 2026, following the satisfaction of the applicable conditions precedent and the receipt of the required approvals, the Company, through its wholly owned subsidiary Suzano International Holding B.V., completed the acquisition of 51% of the share capital of FamPro Tissue Holdings B.V. ("Arbex"), thereby obtaining exclusive control of the entity as of that date. The Company also acquired a call option (“Call Option”) over the remaining 49% interest held by Kimberly-Clark ("K-C"), which is exercisable at Suzano’s sole discretion from the third anniversary of the execution date of the agreement. The transaction is aligned with the Company’s strategy to expand its operations in the consumer goods segment and strengthen its presence in the global tissue market through the incorporation of complementary operations, brands, production capabilities and distribution channels.

The acquisition comprises K-C’s global consumer goods business related to the manufacturing, marketing, distribution and sale of tissue products in certain jurisdictions across the Americas, Europe, Asia, South Africa and Oceania, excluding North America. The transaction includes 22 production facilities located in 14 countries, as well as the transfer of certain regional brands and the royalty-free licensing of K-C’s global brands to Arbex in the regions covered by the transaction.

As a result of the acquisition, the Consumer Goods business became relevant in the context of the Company’s consolidated operations and has operating and economic characteristics that are distinct from those of the Company’s other businesses. Accordingly, considering its increased significance, the business began to be presented separately as a reportable operating segment. Additional information on the criteria used to identify, measure and reconcile the operating segments is presented in Note 5.

The total consideration paid in the transaction amounted to US$1,293 million (equivalent to R$6,717 million) as of the acquisition date.

11

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

Acquisition-related costs incurred in connection with the business combination totaled R$378,293 (R$295,867 in 2026 and R$82,426 in 2025) and were recognized as expenses in profit or loss for the respective periods under general and administrative expenses.

Arbex has been consolidated prospectively from July 1, 2026. During the three-month period ended September 30, 2026 , Arbex contributed R$4,212,359 to consolidated net revenue and a net loss of R$67,246, of which R$238,623 was attributable to the acquiree's net income for the quarter and R$(305,870) related to the amortization of the net fair value adjustments recognized in the purchase price allocation.

If the acquisition had occurred on January 1, 2026, the acquiree's pro forma contribution to the Company's consolidated results would have amounted to pro forma net revenue of R$12,676,116 and pro forma net income of R$160,754 for the nine-month period ended September 30, 2026. This unaudited pro forma financial information was derived from the simple aggregation of the acquiree's results and does not necessarily represent the results that would have been achieved had the acquisition occurred on January 1, 2026. For purposes of preparing this pro forma information, the amortization of the fair value adjustments arising from the business combination was considered only from July 1, 2026 onward.

The preliminary allocation of the fair values of the identifiable assets acquired and liabilities assumed as of the acquisition date, recognized in the purchase price allocation process and incorporated into Suzano's consolidated financial statements from the acquisition date, is presented below.

12

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

Acquisition-date fair value

Assets

Current

Cash and cash equivalents

2,068 

Inventories

2,432 

Trade accounts receivable

3,465 

Total current assets

7,965 

Non-current

Deferred taxes

852 

Property, plant and equipment

12,411 

Right of use

384 

Intangible

2,852 

Other assets

218 

Goodwill

1,730 

Total non-current assets

18,447 

TOTAL ASSETS

26,412 

Liabilities

Current

Trade accounts payable

3,564 

Lease liabilities

104 

Tax liabilities

114 

Accrued employee compensation

360 

Other liabilities

1,235 

Total current liabilities

5,377 

Non-current

Loans, financing and debentures

6,904 

Lease liabilities

281 

Employee-related obligations

125 

Net deferred tax liabilities

1,886 

Other liabilities

249 

Total non-current liabilities

9,445 

TOTAL LIABILITIES

14,822 

SHAREHOLDERS’ EQUITY

11,590 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

26,412 

13

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

The acquisition was accounted for as a business combination in accordance with IFRS 3. The preliminary allocation of the consideration transferred to the identifiable assets acquired and liabilities assumed is presented below:

(amounts expressed in millions of Brazilian reais)

Carrying amount of net assets

5,143 

Fair value adjustments

Inventories (1)

286 

Property, plant and equipment (2)

5,465 

Trademarks and patents (3)

634 

Deferred taxes, net (4)

(1,668)

Goodwill (5)

1,730 

Fair value of net identifiable assets

11,590 

Acquired interest (51%)

5,912 

Non-controlling interest (49%)

5,678 

Consideration transferred

6,717 

Acquisition cost of the call option (6)

(805)

Total consideration transferred in the business combination

5,912 

(1)Calculated considering the balance of finished goods based on selling price, net of selling expenses.

(2)Measured based on the analysis of market data from comparable transactions and on cost quantification, derived from the estimated replacement or reproduction cost of the assets.

(3)Other assets include trademark licensing, measured based on projected revenues from products under the valued brands, in accordance with the Relief from Royalty methodology.

(4)Represents the net deferred income tax and social contribution effect recognized on the temporary differences arising from the fair value adjustments to inventories, property, plant and equipment, and trademarks and patents identified in the acquisition.

(5)Goodwill arising from the acquisition is primarily attributable to the expected synergies from the business combination, Arbex's future profitability potential, and other economic benefits that do not individually meet the criteria for separate recognition as identifiable intangible assets. The non-controlling interest was measured at fair value as of the acquisition date. As a result of this accounting policy election, the goodwill recognized reflects the amount attributable to both the controlling and non-controlling shareholders of the acquiree.

(6)The Share Purchase Agreement includes a call option granting the Company the right, but not the obligation, to acquire the entire remaining 49% equity interest in Arbex held by Kimberly-Clark, subject to the contractual terms and conditions. The fair value of the option was estimated using a Monte Carlo simulation model, which considered prospective scenarios for the investee's value and projected EBITDA through the exercise date, as well as assumptions related to volatility, the risk-free rate and contractual adjustments applicable to the determination of the exercise price. The resulting amount was recognized as a separate component of the consideration transferred in the transaction.

The amounts assigned are preliminary and may be adjusted during the measurement period prescribed by the applicable standard, as the Company completes additional valuation procedures and obtains new information about facts and circumstances that existed as of the acquisition date.

1.2.2 Middle East Crisis

The Company continuously monitors the scenario of geopolitical instability in the Middle East and assesses its potential impacts on the macroeconomic environment, the markets in which it operates, and its operations.

14

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

The Company has employees and facilities in Israel and has been closely monitoring the local situation, adopting security measures and operational protocols in line with the guidance of the competent authorities.

As of the date these consolidated interim financial information were prepared, no material impacts have been identified on the supply of raw materials, logistics, or customer service. The main effects observed relate to increased volatility in energy and commodity costs, which have been managed through the Company’s customary risk mitigation mechanisms.

Based on the analyses conducted to date, Management considers that there is no evidence of material operational or financial impacts on the Company as of September 30, 2026; however, this assessment may be revised as the situation evolves.

2 BASIS OF PREPARATION AND PRESENTATION OF FINANCIAL INFORMATION

The Company’s unaudited condensed consolidated interim financial information, for the three and nine-month period ended September 30, 2026, are prepared in compliance with the international accounting standard IAS 34 Interim Financial Reporting issued by the International Accounting Standards Board (“IASB”) and disclose all the applicable significant information related to the financial information, which is consistent with the information used by Management in the performance of its duties.

The Company’s unaudited condensed consolidated interim financial information are expressed in thousands of Brazilian Reais (“R$”), as well as the amounts of other currencies, when applicable, were also expressed in thousands, unless otherwise stated.

The preparation of unaudited condensed consolidated interim financial information requires Management to make judgments, use estimates and adopt policies in the process of applying accounting practices that affect the disclosed amounts of revenues, expenses, assets and liabilities, including the disclosure of contingent liabilities assumed. However, the uncertainty inherent to these judgments, assumptions and estimates could result in material adjustments to the carrying amount of certain assets and liabilities in future periods.

The Company reviews its judgments, estimates and assumptions continually as disclosed in the annual financial statements for the year ended December 31, 2025 (Note 3.2.19). For the nine-month period ended September 30, 2026, there were no changes in these judgments, estimates and assumptions compared to disclosed on December 31, 2025.

The unaudited condensed consolidated interim financial information was prepared on historical cost basis, except for the following material items recognized:

(i)Derivative and non-derivative financial instruments measured at fair value;

(ii)Share-based payments and employee benefits measured at fair value; and

(iii)Biological assets measured at fair value;

The unaudited condensed consolidated interim financial information has been prepared under the assumption that no material uncertainties exist with respect to events or conditions that may cast significant doubt regarding the Company's capacity to continue operating as going concern.

15

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

3 SUMMARY OF MATERIAL ACCOUNTING POLICIES

The unaudited condensed consolidated interim financial information was prepared based on the information of Suzano and its subsidiaries on the same base date, except for associates Biomas, Simplifyber and Spinnova, as well as in accordance with consistent accounting policies and practices.

The unaudited condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended December 31, 2025, considering that its purpose is to provide an update on the activities, events and significant circumstances in relation to those disclosed in the consolidated financial statements. Therefore, unaudited condensed consolidated interim financial information focus on new activities, events and circumstances and do not duplicate the information previously disclosed, except when Management judges that the maintenance of the information is relevant.

The accounting policies have been consistently applied to all consolidated companies.

There were no changes on such policies and estimates calculation methodologies, except for the new accounting policies presented in Note 3.1, adopted as of January 1, 2026 which were disclosed in the annual financial statements of December 31, 2025, and for the accounting policy updates presented in Note 3.2, adopted as of July 1, 2026, as a result of the acquisition of Arbex.

3.1 New accounting policies and changes in accounting policies adopted

The new standards and interpretations issued, until the issuance of the Company’s unaudited condensed consolidated interim financial information, are described below.

3.1.1 Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial Instruments (applicable for annual on/or after January 1, 2026)

On 30 May 2024, the IASB issued targeted amendments to IFRS 9 and IFRS 7 to respond to recent questions arising in practice, and to include new requirements not only for financial institutions but also for corporate entities. These amendments:

•clarify the date of recognition and derecognition of some financial assets and liabilities, with a new exception for some financial liabilities settled through an electronic cash transfer system;

•clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion;

•add new disclosures for certain instruments with contractual terms that can change cash flows (such as some financial instruments with features linked to the achievement of environment, social and governance targets); and

•update the disclosures for equity instruments designated at fair value through other comprehensive income (FVOCI).

The Company assessed the content of this pronouncement and did not identify any impacts.

3.2 Accounting policies updated in 2026 as a result of the Arbex acquisition

As a result of the acquisition of Arbex and the incorporation of new operations into Suzano's consolidated operations, the Company introduced or updated certain accounting policies in 2026. The changes relate to:

(i) Translation of financial statements into the functional and presentation currency: the inclusion of Arbex among the foreign subsidiaries whose functional currency is not the Brazilian Real. Arbex’s functional currency is the Euro.

16

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

Additionally, Arbex's investees have different functional currencies, determined based on the primary economic environment in each jurisdiction in which they operate. For consolidation purposes, their financial statements are translated into the Suzano consolidated financial statements' presentation currency in accordance with the applicable accounting standards.

(ii) Segment information: as a result of the acquisition of Arbex's operations, the Consumer Goods segment became significant for segment reporting purposes and is now reported in addition to the Pulp and Paper and Packaging segments previously disclosed (Note 5).

(iii) Financial instruments: the Company supplemented its financial instruments policy to include the criteria applicable to the recognition, measurement and disclosure of financial instruments designated in hedge accounting relationships, in line with the risk management strategies adopted by Suzano. This addition reflects the need to appropriately account for certain hedging transactions entered into by Arbex and does not represent a change in the Company’s financial risk management objectives (Note 4.5.4).

(iv) Material accounting judgments, estimates and assumptions: business combinations have become a matter subject to critical judgments and estimates. The measurement of the fair value of acquired assets and assumed liabilities, as well as the determination of goodwill, involves significant assumptions and the use of information available at the acquisition date. Changes in these assumptions or new information obtained during the measurement period may result in adjustments to the amounts initially recognized (Note 1.2.1).

All other accounting policies remain consistent with those disclosed in the financial statements as of December 31, 2025.

4 FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT

4.1 Financial risks management

4.1.1 Overview

In the nine-month period ended September 30, 2026, there were no transfers of financial instruments between Levels 1, 2 and 3 of the fair value hierarchy and there were no significant changes in the financial risk management policies and procedures compared to those disclosed in the annual financial statements for the year ended December 31, 2025 (Note 4), except for those mentioned in Note 3.2.

The Company maintained its conservative approach and strong cash and marketable securities position, as well as its hedging policy.

4.1.2 Classification

All transactions with financial instruments are recognized for accounting purposes and classified in the following categories:

17

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

Note09/30/202612/31/2025
Assets
Amortized cost

Cash and cash equivalents

9

13,406,218 

15,179,753 

Trade accounts receivable

11

8,469,460 

6,560,607 

Other assets (1)

1,079,301 

595,069 

22,954,979 

22,335,429 

Fair value through other comprehensive income

Investments (2)

18.1

743,848 

901,181 

743,848 

901,181 

Fair value through profit or loss

Derivative financial instruments (3)

4.5.1

13,156,135 

9,571,661 

Marketable securities (4)

10

8,151,855 

10,252,454 

Call option (5)

1.2.1

803,040 

22,111,030 

19,824,115 

45,809,857 

43,060,725 

Liabilities
Amortized cost

Trade accounts payable

21

8,728,141 

5,141,386 

Loans, financing and debentures

22.1

97,842,847 

94,801,257 

Lease liabilities

23.2

7,127,247 

6,929,890 

Dividends payable

7,351 

1,393,121 

Other liabilities (1)

393,944 

236,724 

114,099,530 

108,502,378 

Fair value through other comprehensive income

Derivative financial instruments (3)

4.5.1

15,244 

15,244 

Fair value through profit or loss

Derivative financial instruments (3)

4.5.1

7,512,705 

9,341,349 

7,512,705 

9,341,349 

121,627,479 

117,843,727 

75,817,622 

74,783,002 

(1)Includes only items classified as financial instruments.

(2)Investments in publicly traded companies are classified as Level 1 in the fair value hierarchy and total R$711,601 as of September 30, 2026 (R$865,986 as of December 31, 2025). Investments in privately held companies are classified as Level 3 and total R$32,247 as of September 30, 2026 (R$35,195 as of December 31, 2025).

(3)Financial instruments classified as Level 2 in the fair value hierarchy.

(4)Government securities are financial instruments classified as Level 1 in the fair value hierarchy and total R$ 1,344,419 as of September 30, 2026 (R$1,274,439 as of December 31, 2025). Private securities, investment funds, and other financial investments are classified as Level 2 in the fair value hierarchy and total R$ 6,807,436 as of September 30, 2026 (R$8,978,015 as of December 31, 2025).

(5)Refers to the call option over the remaining equity interest held by non-controlling shareholders, associated with the transaction described in Note 1.2.1 and classified within Level 3 of the fair value hierarchy. The fair value of the option was estimated using a Monte Carlo simulation model, which considered prospective scenarios for the value of the investee, taking into account assumptions related to projected EBITDA, volatility, the risk-free rate, and the contractual adjustments contemplated in determining the exercise price. The measurement is sensitive, among other factors, to the discount rate applied in the valuation model, which may be affected by changes in macroeconomic conditions, perceptions of business risk, and the cost of capital required by market participants. Considering an isolated 1 percentage point change in this rate, with all other assumptions held constant, the fair value of the option would be impacted by R$77,141.

18

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

4.1.3 Fair value of loans and financing

The estimated fair values of loans and financing are set forth below:

Yield used to discount/methodology09/30/202612/31/2025
Quoted in the secondary market

In foreign currency

Bonds (1)

Secondary Market

37,233,909 

42,223,976 

Estimated present value

In foreign currency

Export credits (“Prepayment”)

SOFR

16,571,351 

18,404,795 

Assets Financing

SOFR

193,395 

277,172 

IFC - International Finance Corporation

SOFR

5,372,365 

5,442,675 

ECA - Export Credit Agency

SOFR

1,864,955 

1,979,202 

Panda Bonds - CNY

Fixed

1,976,248 

1,964,329 

Term Loan Syndicated Facility

EURIBOR

6,818,702 

In local currency

BNDES – TJLP

DI 1

32,489 

95,167 

BNDES – TLP

DI 1

4,211,994 

4,193,766 

BNDES – Fixed

DI 1

61,115 

BNDES – TR

DI 1

85,261 

90,356 

BNDES – Selic (“Special Settlement and Custody System”)

DI 1

69,750 

547,000 

BNDES – UMBNDES

DI 1

34,580 

253,500 

Assets Financing

DI 1

39,066 

49,911 

Debentures

DI 1/IPCA

11,397,761 

10,873,596 

NCE (“Export Credit Notes”)

DI 1

107,926 

105,865 

NCR (“Rural Credit Notes”)

DI 1

5,580,245 

5,520,478 

CPR ("Rural Product Notes")

DI 1

3,035,723 

1,472,697 

ECO INVEST – Agroindustrial Credit

DI 1

451,266 

334,422 

95,138,101 

93,828,907 

(1) The fair value presented in the Financial Statements as of December 31, 2025 did not include one of the 2029 Bond series, in the amount of R$ 5,568,313. Considering the inclusion of this amount, the fair value previously reported as of December 31,2025, in the amount of R$ 36,655,663, was revised to R$ 42,223,976.

The book values of loans and financing are disclosed in Note 22.1.

Management considers that, for its other financial assets and liabilities measured at amortized cost, their book values approximate their fair values, and therefore the fair value information is not being presented.

4.2 Liquidity risk management

As disclosed in the financial statements for the year ended December 31, 2025 (Note 4), the Company’s purpose is to maintain a strong cash and marketable securities position to meet its financial and operating commitments. The amount held in cash is intended to cover the expected outflows in the normal course of its operations, while the cash surplus is generally invested in highly liquid financial investments according to the Cash Management Policy.

19

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

The cash position is monitored by the Company’s Management, by means of management reports and participation in performance meetings with determined frequencies. During the nine-month period ended September 30, 2026, the variations in cash and marketable securities were as expected, and the cash generated from operations was mostly used for investments and debt service.

All derivative financial instruments were traded over the counter and do not require deposit guarantee margins.

The remaining contractual maturities of financial liabilities are presented as of the balance sheet date. The amounts as set forth below consist of undiscounted cash flow, and include interest payments and exchange rate variations, and therefore may not reconcile with the amounts disclosed in the balance sheet.

09/30/2026
Book valueUndiscounted cash flowUp to 1 year1 - 2 years2 - 5 yearsMore than 5 years
Liabilities

Trade accounts payables

8,728,141 

8,728,141 

8,728,141 

Loans, financing and debentures

97,842,847 

133,508,868 

7,374,277 

10,114,333 

65,061,024 

50,959,234 

Lease liabilities

7,127,247 

12,004,117 

1,638,904 

1,347,389 

3,323,841 

5,693,983 

Derivative financial instruments

7,527,949 

13,270,486 

1,268,117 

1,042,840 

3,959,783 

6,999,746 

Dividends payable

7,351 

7,351 

7,351 

Other liabilities

393,944 

427,242 

172,650 

238,424 

16,168 

121,627,479 

167,946,205 

19,189,440 

12,742,986 

72,360,816 

63,652,963 

12/31/2025
Book
value
Undiscounted cash flowUp to 1 year1 - 2 years2 - 5 yearsMore than 5 years
Liabilities

Trade accounts payables

5,141,386 

5,141,386 

5,141,386 

Loans, financing and debentures

94,801,257 

136,586,565 

5,690,098 

16,894,643 

46,428,491 

67,573,333 

Lease liabilities

6,929,890 

13,281,230 

2,761,632 

1,235,951 

3,161,325 

6,122,322 

Derivative financial instruments

9,341,349 

13,741,567 

1,139,273 

849,920 

3,815,705 

7,936,669 

Dividends payable

1,393,121 

1,393,121 

1,393,121 

Other liabilities

236,724 

256,992 

69,458 

111,323 

76,211 

117,843,727 

170,400,861 

16,194,968 

19,091,837 

53,481,732 

81,632,324 

4.3 Credit risk management

In the nine-month period ended September 30, 2026, there were no significant changes in the credit risk management policies compared to those disclosed in the annual financial statements for the year ended of December 31, 2025 (Note 4).

4.4 Market risk management

In the nine-month period ended September 30, 2026, there were no significant changes in the market risk management policies and procedures compared to those disclosed in the annual financial statements for the year ended December 31, 2025 (Note 4).

20

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

4.4.1 Exchange rate risk management

As disclosed in the financial statements for the year ended December 31, 2025 (Note 4), the Company enters into US$ selling transactions in the futures markets, including strategies involving options, to ensure attractive levels of operating margins for a portion of revenue. Such transactions are limited to a percentage of the net surplus foreign currency over a 36-month time horizon and therefore, are matched to the availability of currency for sale in the short term.

Additionally, the Company enters into derivative financial instruments linked to other currencies in order to align the foreign exchange index of its debt with the currency in which it generates cash flows, in accordance with its financial risk management policies. The assets and liabilities exposed to foreign currency risk, are presented below:

Sensitivity analysis
Exchange rate risk (Effect on profit or loss)                
Base value
Probable
09/30/2026
Possible (25%)Remote (50%)

Cash and cash equivalents

8,575,216 

(2,143,804)

(4,287,608)

Marketable securities

271,405 

(67,851)

(135,703)

Trade accounts receivable

6,650,540 

(1,662,635)

(3,325,270)

Trade accounts payable

(4,465,489)

(1,116,372)

(2,232,745)

Loans and financing

(70,939,688)

(17,734,922)

(35,469,844)

Other liabilities

(46,252)

(11,563)

(23,126)

Derivative financial instruments

Derivative options

3,013,886 

(4,321,580)

(8,588,587)

Derivative swaps

1,855,586 

(3,741,488)

(7,441,409)

Derivative Non-Deliverable Forward (‘NDF’) Contracts

8,423 

(146,150)

(293,534)

Embedded derivatives

210,360 

(152,255)

(304,509)

Commodity derivatives

328,911 

(82,259)

(164,493)

Forward contracts

24,893 

(120,439)

(240,878)

For market risk analysis, the Company uses scenarios to evaluate both its asset and liability positions in foreign currency, and the possible effects on its results. The probable scenario represents the amounts recognized, as they reflect the conversion into Brazilian Reais on the balance sheet date. For the calculation of the mark-to-market (“MtM”) price, the exchange rate of the last business day of the period is used.

This analysis below assumes that all other variables, particularly the interest rates, remain constant. The other scenarios considered the variation of the Brazilian Real against the US$ by 25% and 50%, before taxes, based on the base scenario on September 30, 2026.

4.4.2 Interest rate risk management

Fluctuations in interest rates could increase or reduce the costs of new loans and existing contracted operations.

The Company is constantly looking for alternatives for the use of financial instruments in order to avoid negative impacts on its cash flow due to fluctuations in interest rates in Brazil or abroad.

21

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

Sensitivity analysis
Interest rate risk (Effect on profit or loss)
Base value
Probable
09/30/2026
Possible (25%)Remote (50%)
CDI/SELIC

Cash and cash equivalents

2,829,959 

(96,572)

(193,145)

Marketable securities

5,489,681 

(187,335)

(374,671)

Loans and financing

8,182,406 

(279,225)

(558,449)

Derivative financial instruments

Derivative options

3,013,886 

(495,011)

(949,434)

Derivative swaps

1,855,585 

(512,489)

(924,836)

TJLP

Loans and financing

34,960 

(799)

(1,598)

IPCA

Marketable securities

1,344,419 

(15,394)

(30,787)

Loans and financing

14,926,206 

(170,905)

(341,810)

SOFR

Loans and financing

22,631,659 

(220,659)

(441,317)

Derivative swaps

1,812,582 

(154,070)

(301,271)

EURIBOR

Loans and financing

6,831,051 

(44,692)

(89,384)

For its market risk analysis, the Company uses scenarios to evaluate the sensitivity of changes in operations impacted by the following rates: Interbank Deposit Rate (“CDI”), Long Term Interest Rate (“TJLP”), Long Term Rate ("TLP"), Special System for Settlement and Custody (“SELIC”), SOFR and EURIBOR, which could impact the results. The probable scenario represents the amounts already booked, as they reflect Management’s best estimates.

This analysis assumes that all other variables, particularly exchange rates, will remain constant. The other scenarios considered an exposure of 25% and 50% in market interest rates before taxes.

4.4.2.1 Sensitivity analysis to changes in the consumer price indices of the US economy

For the measurement of the probable scenario, the United States Consumer Price Index (“US-CPI”) was considered on September 30, 2026. The probable scenario was extrapolated considering an appreciation of 25% and 50% in the US-CPI to define the possible and remote scenarios, respectively.

The following table sets out the possible impacts, assuming these scenarios in absolute amounts:

09/30/2026
Effect on profit or loss
Probable (base value)Possible (25%)Remote (50%)

Embedded derivative in a commitment to purchase standing wood, originating from a forest partnership agreement

210,360 

(31,615)

(68,057)

22

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

4.4.3 Pulp and commodity price risk management

The Company is primarily exposed to the selling prices of pulp and other commodities in the international market. The dynamics of rising and falling production capacities in the global market and macroeconomic conditions may impact the Company´s operating results.

To manage these exposures, the Company continuously monitors hardwood pulp prices and analyses future trends, updating its projections to support the adoption of preventive measures under a range of market scenarios. There is no sufficiently liquid financial market capable of adequately mitigating the risk associated with a significant portion of the Company’s operations. Hardwood pulp price protection instruments available on the market have low volume and high levels of distortion in price formation.

Another significant exposure relates to international oil prices, reflected in export logistical costs, and indirectly in costs of supplies and services. In such cases, the Company evaluates whether to contract derivative financial instruments to mitigate the risk of price variations in its results, in accordance with the Company's hedging policy.

The Company is also exposed to the risk of fluctuations in electricity market prices as a result of a Virtual Power Purchase Agreement (VPPA). The financial settlement of this agreement is determined based on the difference between the contractually agreed price and the prevailing market price of electricity, reflecting movements in market prices. This exposure is monitored in accordance with the Company's risk management guidelines.

4.5 Derivative financial instruments

The Company determines the fair value of derivative contracts, which differ from the amounts realized in the event of early settlement due to bank spreads and market factors at the time of quotation. The amounts presented by the Company are based on an estimate using market factors and use data provided by third parties, measured internally and compared to calculations performed by external consultants and by counterparties.

Details of derivative financial instruments and their respective calculation methodologies are disclosed in the annual financial statements for the year ended December 31, 2025 (Note 4).

23

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

4.5.1 Outstanding derivatives by contract type, including embedded derivatives

The positions of outstanding derivatives are set forth below:

Notional value (1)

Fair value in R$
Currency09/30/202612/31/202509/30/202612/31/2025
Debt hedges
Assets

Swap CDI to Fixed

BRL

12,461,384 

8,788,534 

2,775,687 

2,525,172 

Swap SOFR to Fixed

USD

2,330,816 

2,400,260 

948,548 

492,458 

Swap IPCA to CDI

BRL

13,945,882 

11,059,169 

2,069,121 

1,549,779 

Pre-fixed Swap to CDI

BRL

2,145,863 

2,400,000 

1,686,589 

1,562,789 

Swap CDI to SOFR

BRL

3,399,600 

3,399,600 

808,112 

915,431 

Swap RMB to Fixed

RMB

2,600,000 

2,600,000 

597,172 

509,116 

8,885,229 

7,554,745 

Liabilities

Swap CDI to Fixed

USD

2,345,159 

1,635,783 

(1,724,042)

(2,686,614)

Swap SOFR to Fixed

USD

2,330,816 

2,400,260 

(460,741)

(400,210)

Swap IPCA to CDI

BRL

12,964,215 

10,466,620 

(2,491,014)

(2,210,556)

Pre-fixed Swap to CDI

BRL

2,145,863 

2,400,000 

(1,221,693)

(1,554,427)

Swap CDI to SOFR

USD

660,171 

660,171 

(688,371)

(1,080,537)

Swap RMB to Fixed

USD

362,736 

362,736 

(443,782)

(473,828)

(7,029,643)

(8,406,172)

1,855,586 

(851,427)

Cash flow hedge

Zero Cost Collar (US$ x R$)

USD

4,763,750 

6,156,400 

3,013,886 

979,705 

NDF (R$ x US$)

USD

105,000 

90,000 

8,423 

24,355 

Forward Contracts

USD

304,000 

24,893 

3,047,202 

1,004,060 

Commodity Hedge and other

Swap US-CPI (standing wood) (2)

USD

148,782 

153,342 

210,360 

112,058 

Zero Cost Collar (Brent)

USD

233,655 

359,677 

328,911 

(33,279)

Power purchase agreement (VPPAs) (3)

USD

154,913 

186,127 

Swap VLSFO/Brent

USD

1,217 

(1,100)

725,398 

77,679 

5,628,186 

230,312 

Current assets

4,108,590 

1,556,978 

Non-current assets

9,047,545 

8,014,683 

Current liabilities

(1,192,092)

(1,205,029)

Non-current liabilities

(6,335,857)

(8,136,320)

5,628,186 

230,312 

(1)The notional amounts reflect exclusively the remaining months of the hedge and do not include the financial settlements that remain outstanding for the subsequent period.

(2)The embedded derivative refers to a swap contract for the sale of price variations in US$ and US-CPI within the term of a forest partnership with a standing wood supply contract.

(3)Refers to a virtual power purchase agreement (VPPA), under which financial settlement is determined based on the difference between the contractually agreed price and the market price of electricity.

24

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

The variation in the fair values of derivatives on September 30, 2026 compared to the fair values measured on December 31, 2025 are explained substantially by the appreciation of the Brazilian Real against the US$ and by settlements during the period. There were also impacts caused by the variations in the Pre Fixed, Foreign Exchange Coupon and SOFR curves in the operations.

It is important to highlight that the outstanding agreements on September 30, 2026 are over-the-counter market operations, without any type of collateral margin or forced early settlement clause due to variations from market marking.

4.5.2 Fair Value Maturity Schedule (net amounts)

09/30/202612/31/2025

2026

848,821 

351,949 

2027

2,871,637 

674,290 

2028

595,737 

96,273 

2029 onwards

1,311,991 

(892,200)

5,628,186 

230,312 

4.5.3 Fair value settled amounts

The settled derivatives positions are set forth below:

09/30/202612/31/2025
Cash flow hedge

Zero Cost Collar (US$)

722,045 

9,922 

NDF (US$)

102,940 

(15,388)

NDF (€ x US$)

(26)

Forward Contracts

7,637 

832,622 

(5,492)

Commodity Hedge and other

Zero Cost Collar (Brent)

285,428 

(712)

285,428 

(712)

Debt hedges

Swap CDI to Fixed (US$)

628,520 

408,373 

Swap IPCA to CDI (Brazilian Reais)

(434,890)

(321,139)

Swap Pre-Fixed to CDI

(509,820)

Swap RMB to fixed US$

(16,455)

Swap SOFR to SOFR (US$)

1,504 

Swap CDI to SOFR (US$)

265,758 

212,326 

Swap SOFR to Fixed (US$)

67,034 

252,250 

16,602 

536,859 

1,134,652 

530,655 

25

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

4.6 Cybersecurity

Suzano has a Public Information Security Policy, which aims to establish guidelines regarding cyber security management and controls at Suzano, seeking to mitigate vulnerabilities, preserve and protect assets, mainly information and personal data, in accordance with current laws, regulations and contractual obligations, covering the confidentiality, integrity, availability, authenticity and legality of information. The Policy establishes responsibilities to avoid damages, which may represent financial impacts, image and reputation, exposure of information, interruption of operations, among other damages due to cyber-attacks.

For the nine-month period ended September 30, 2026, no material incidents associated with cybersecurity were identified that could affect the confidentiality, integrity and/or availability of the systems used by the Company.

4.7 Climate change

In the annual financial statements for the year ended December 31, 2025, the Company disclosed information on the risks and opportunities related to climate change and its sustainability strategy. In the nine-month period ended September 30, 2026, there were no significant changes in these risks. The update, during the period, to the status of sustainability targets linked to financial instruments—reflecting the achievement of the target for women in leadership positions and the non‑achievement of the GHG emissions intensity target—resulted mainly in the application of a 25‑basis‑point step‑up in the interest rate of the 2031 SLB, from 3.75% to 4.00%, effective June 16, 2026. The water withdrawal intensity target remains under measurement, with verification expected by the end of the 2026 fiscal year.

4.8 Capital management

The main objective is to strengthen the Company’s capital structure, aiming to maintain an appropriate level of financial leverage while mitigating risks that could affect the availability of capital for business development.

The Company continuously monitors significant indicators, such as consolidated financial leverage, which is the ratio of total net debt to adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (“Adjusted EBITDA”).

26

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

5 SEGMENT INFORMATION

5.1 Criteria for identifying operating segments

The Company’s chief operating decision maker ("CODM"), comprising the Board of Directors and the Board of Statutory Executive Officers, evaluates the performance of the Company’s operating segments based on Adjusted EBITDA.

Until June 30, 2026, the Company reported two operating segments: (i) Pulp; and (ii) Paper and Packaging. As a result of the acquisition described in Note 1.2.1, the Consumer Goods business increased in significance and began to meet the quantitative thresholds for separate disclosure set forth in IFRS 8. Accordingly, beginning on July 1, 2026, Consumer Goods, which had previously been aggregated within the Paper and Packaging segment, has been presented separately as a reportable segment.

The Company’s reportable segments are as follows:

i)Pulp: comprises of the production and sale of hardwood eucalyptus pulp and fluff pulp, mainly to supply the foreign market.

ii)Paper and Packaging: comprises the production and sale of paper and packaging products for domestic and foreign markets.

iii)Consumer Goods (Tissue): comprises the production and sale of personal care and consumer tissue products for domestic and foreign markets.

The information attributed to the Company’s segments are measured consistently with the practices historically adopted by the Company. For purposes of evaluating segment performance, the results of the Pulp segment and the Paper and Packaging segment consider the cost of pulp. In turn, the tail price methodology (market reference price) is used specifically for transactions involving the transfer of pulp to the Consumer Goods (Tissue) segment.

As this methodology reflects the manner in which the Company's chief operating decision maker ("CODM") assesses business performance, certain amounts of net sales and cost of sales for the Pulp and Consumer Goods (Tissue) segments differ from those previously presented due to the elimination of intersegment transactions. This change, however, had no impact on the previously reported consolidated amounts.

5.2 Information of operating segments

09/30/2026

Pulp

(1)

Paper and Packaging

(1)

Consumer Goods

(1)

Intersegment eliminations

(1) (2)

Total

Net sales

27,075,152 

6,515,817 

6,429,653 

(946,529)

39,074,093 

Cost of sales

(19,663,237)

(5,143,043)

(5,179,127)

819,125 

(29,166,282)

Adjusted EBITDA

13,257,622 

950,031 

961,675 

(210,391)

14,958,937 

Adjustments to EBITDA (*)

883,075 

Depreciation, depletion and amortization

(9,674,850)

Financial result

5,752,130 

Net income before taxes

11,919,292 

27

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

09/30/2025

Pulp

(1)

Paper and Packaging

(1)

Consumer Goods

(1)

Intersegment eliminations

(1) (2)

Total

Net sales

28,522,725 

6,937,020 

2,115,443 

(573,227)

37,001,961 

Cost of sales

(18,827,677)

(5,053,379)

(1,483,223)

573,227 

(24,791,052)

Adjusted EBITDA

14,492,827 

1,400,803 

259,858 

16,153,488 

Adjustments to EBITDA (*)

(823,557)

Depreciation, depletion and amortization

(8,226,217)

Financial result

13,172,959 

Net income before taxes

20,276,673 

(1)As described in Note 1.2.1, following the acquisition of Arbex and the resulting increase in the financial significance of the Consumer Goods operating segment, the segment became reportable under IFRS 8, Operating Segments. Accordingly, the Consumer Goods segment is now presented separately in the Company’s segment disclosures. The information disclosed for this segment reflects the Tail Price methodology applied to the measurement of transactions involving pulp used in the manufacture of tissue products, based on a market reference price. The comparative segment information has been recast to reflect the separate presentation of this reportable segment and the application of the Tail Price methodology, ensuring consistency and comparability with the presentation adopted in the current period (as originally presented at September 30, 2025: Pulp – net sales – R$27,949,498 | Pulp – cost of sales – R$(18,535,613) | Pulp – adjusted EBITDA – R$14,093,769 | Paper – net sales – R$9,052,463 | Paper – cost of sales – (R$6,255,439) | Paper – adjusted EBITDA – R$2,059,719).

(2)Intersegment eliminations do not represent an operating segment. For the nine-month period ended September 30, 2026, the amounts presented in this column comprise: (i) the elimination of intersegment revenue and corresponding costs; (ii) the elimination of unrealized profits on intersegment transactions; and (iii) reconciliation adjustments arising from the tail-price mechanism. These adjustments impact the allocation of net sales, cost of sales and Adjusted EBITDA across the operating segments and are fully eliminated upon consolidation, with no effect on consolidated results.

09/30/202609/30/2025
(*) Adjustments to EBITDA

Fair Value - Biological Asset

1,157,728 

(73,248)

Loss from associates and joint ventures

(33,572)

(268,350)

Impairment of subsidiaries (1)

(88,871)

Income (loss) on disposal and write-off of non-current assets

146,036 

(183,356)

(Provision)/Reversals for losses on ICMS credits (note 13.1)

(29,756)

(151,669)

Expenses on Asset Acquisition and Business Combinations (2)

(295,867)

(41,423)

Restructuring expenses (3)

(64,219)

(106)

Others (4)

2,725 

(16,534)

883,075 

(823,557)

(1)Refers to the impairment of the investment in the subsidiary Suzano Finland Oy and the joint venture Woodspin Oy, as detailed in Note 18.3.

(2)Acquisition-related costs associated with business combinations, including fees paid to external advisors and professional service providers, such as legal, accounting, valuation and other consulting services, administrative expenses related to acquisition processes, and other costs directly attributable to the execution of such transactions.

(3)Costs incurred directly in connection with restructuring initiatives, including changes to the management, administrative, and organizational structure, and costs associated with the discontinuation of operations.

(4)It includes items with specific, non-cash and exceptional adjustments, such as: i) effective loss of the development contract advance program; (ii) write-off of stacked wood inventory; and (iii) extemporaneous tax credits.

28

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

5.2.1 Net Sales by geographic region

09/30/2026
PulpPaper and PackagingConsumer Goods

Geographic Region (1)

Domestic market (Brazil)

1,823,420 

3,267,655 

2,192,426 

Asia and Oceania

12,213,307 

26,363 

1,124,468 

Europe

7,539,584 

276,934 

2,084,954 

North America

4,989,032 

2,262,555 

South America and Central America

393,414 

650,790 

875,455 

South Africa

116,395 

31,520 

152,350 

Total geographic information

27,075,152 

6,515,817 

6,429,653 

09/30/2025
PulpPaper and PackagingConsumer Goods

Geographic Region (1)

Domestic market (Brazil)

1,939,868 

3,251,247 

2,097,729 

Asia and Oceania

13,312,386 

30,749 

Europe

7,931,962 

263,754 

North America

4,864,271 

2,564,390 

South America and Central America

466,587 

795,350 

17,714 

South Africa

7,651 

31,530 

Total geographic information

28,522,725 

6,937,020 

2,115,443 

(1)Geographic information is presented on the same measurement basis as the segment information regularly reviewed by the Company’s chief operating decision maker (“CODM”). This measurement basis includes intersegment transactions, which are eliminated upon consolidation. Additionally, the comparative information for September 30, 2025, has been recast to incorporate the tail price methodology and the new reportable segment.

5.2.2 Net sales by product

09/30/202609/30/2025
Products

Market pulp (1)

27,075,152 

28,522,725 

Printing and writing paper

3,844,689 

3,870,255 

Paperboard

2,646,317 

3,036,987 

Consumer Goods

6,429,653 

2,115,443 

Other

24,811 

29,778 

Intersegment eliminations (2)

(946,529)

(573,227)

39,074,093 

37,001,961 

(1)Net sales of fluff pulp represent 0.6% of total net sales, and therefore were included in market pulp net sales. (0.7% as at September 30, 2025).

(2)Intersegment eliminations do not represent an operating segment. For the nine-month period ended September 30, 2026, the amounts presented in this column comprise: (i) the elimination of intersegment revenue and corresponding costs; (ii) the elimination of unrealized profits on intersegment transactions; and (iii) reconciliation adjustments arising from the tail price methodology. These adjustments impact the allocation of net sales, cost of sales and Adjusted EBITDA across the operating segments and are fully eliminated upon consolidation, with no effect on consolidated results. Additionally, the comparative information for September 30, 2025, has been recast to incorporate the tail price methodology and the new reportable segment.

29

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

5.3 Main customers

On September 30, 2026, the Company had 1 (one) customer responsible for 10.80% (11.06% on September 30, 2025) of the net sales of Pulp segment and 1 (one) customer responsible for 16.40% (10.70% on September 30, 2025) of the net sales of the Paper and Packaging segment. In the Consumer Goods (Tissue) segment, no customer represented 10.00% or more of net sales revenue on September 30, 2026 and 2025.

5.4 Goodwill based on expected future profitability

The goodwill based on expected future profitability arising from the business combination was allocated to the disclosable segments, which correspond to the Company's cash-generating units (“CGUs”), considering the economic benefits generated by such intangible assets. The allocation of goodwill is set out below:

09/30/202612/31/2025

Pulp

7,897,051 

7,897,051 

Consumer Goods

2,020,667 

290,191 

9,917,718 

8,187,242 

6 NET SALES

09/30/202609/30/2025

Gross sales

49,865,656 

44,717,590 

Sales deductions

Returns and cancellations

(162,670)

(102,022)

Discounts and rebates

(8,975,411)

(5,930,234)

40,727,575 

38,685,334 

Taxes on sales

(1,653,482)

(1,683,373)

Net sales

39,074,093 

37,001,961 

30

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

7 INCOME (EXPENSES) BY NATURE

09/30/202609/30/2025

Cost of sales (1)

Personnel expenses

(1,749,978)

(1,655,870)

Costs of raw materials, materials and services

(12,245,087)

(10,193,836)

Logistics cost

(4,773,756)

(4,583,146)

Depreciation, depletion and amortization

(8,858,204)

(7,410,834)

Other

(1,539,257)

(947,366)

(29,166,282)

(24,791,052)

Selling expenses

Personnel expenses

(264,317)

(281,771)

Services

(195,055)

(184,625)

Logistics cost

(1,225,448)

(1,077,476)

Depreciation and amortization

(737,935)

(727,420)

Other (2)

(348,871)

(171,801)

(2,771,626)

(2,443,093)

General and administrative expenses

Personnel expenses

(1,463,647)

(1,217,486)

Services

(583,700)

(406,502)

Depreciation and amortization

(135,443)

(95,173)

Other (3)

(202,994)

(266,809)

(2,385,784)

(1,985,970)

Other operating (expenses) income, net

Results from sales of other products, net

129,171 

85,309 

Net result on disposal and write-off of non-current assets

146,036 

(272,228)

Result on fair value adjustment of biological assets

1,157,728 

(73,248)

Depreciation, amortization and other PPA realizations (4)

56,732 

7,210 

Provision for judicial liabilities

(110,489)

(155,276)

Other operating income, net (5)

71,155 

(1,549)

1,450,333 

(409,782)

(1)Includes R$935,616 related to maintenance downtime costing (R$485,199 as at September 30, 2025).

(2)Includes expected credit losses, insurance, materials for use and consumption, travel, accommodation, trade fairs and events.

(3)Includes, substantially corporate expenses, insurance, materials for use and consumption, social programs and donations, travel and accommodation.

(4)Refers, substantially, to the write-off of contingent liabilities assumed in Fibria's PPA as disclosed in note 24.1.

(5)In 2026, this amount primarily relates to the recognition of tax credits pertaining to prior periods.

31

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

8 NET FINANCIAL RESULT

09/30/202609/30/2025

Financial expenses

Interest on loans, financing and debentures (1)

(4,364,050)

(4,194,406)

Premium expenses on early settlements (2)

(204,416)

(89,026)

Amortization of transaction costs

(117,573)

(75,916)

Interest expenses on lease liabilities (3)

(333,734)

(347,320)

Other

(333,900)

(363,271)

(5,353,673)

(5,069,939)

Financial income

Cash and cash equivalents and marketable securities

1,382,280 

1,144,245 

Other

137,003 

139,962 

1,519,283 

1,284,207 

Results from derivative financial instruments

Income

9,798,516 

9,008,280 

Expenses

(3,296,705)

(1,576,658)

6,501,811 

7,431,622 

Monetary and exchange rate variations, net

Exchange rate variations on loans, financing and debentures

3,588,489 

10,914,087 

Leases

144,326 

381,893 

Other assets and liabilities (4)

(648,106)

(1,768,911)

3,084,709 

9,527,069 

Net financial result

5,752,130 

13,172,959 

(1)Excludes R$50,725 arising from capitalized loan costs (R$205,409 as at September 30, 2025).

(2)R$121,752 related to the costs of early termination of the pre‑approved and undrawn credit facility with Finnvera.

(3)Includes R$201,609 eliminated resulting from the reclassification to the biological assets item for inclusion in the cost of formation (R$200,177 in the Consolidated as of September 30, 2025).

(4)Includes effects of exchange rate variations of trade accounts receivable, trade accounts payable, cash and cash equivalents, marketable securities and others.

9 CASH AND CASH EQUIVALENTS

Average yield p.a. %09/30/202612/31/2025

Cash and banks (1)

3.71

%

9,481,241 

9,881,326 

Cash equivalents
Local currency

Fixed-term deposits

101.39

% of CDI

2,829,959 

3,204,403 

Foreign currency

Fixed-term deposits (2)

2.58%

1,095,018 

2,094,024 

13,406,218 

15,179,753 

(1)Refers mainly to investments in foreign currency under the Sweep Account program, which is a remunerated account the balance of which is invested and made available automatically each day.

(2)Refers to Time Deposit investments, with maturities of up to 90 days, which are remunerated bank deposit with a specific maturity period and are subject to an insignificant risk of changes in value.

32

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

10 MARKETABLE SECURITIES

Average yield p.a. %09/30/202612/31/2025
In local currency

Private funds

97.75% of CDI

541,111 

526,526 

Private Securities ("CDBs")

101.32% of CDI

4,599,861 

7,045,434 

Public Securities

IPCA + 6.15

%

1,344,419 

1,274,439 

CDBs - Escrow Account (1)

99.55% of CDI

348,709 

319,680 

Public Securities - Instituto de Crédito Oficial (ICO)

12.06%

1,031,026 

633,428 

Other

TR + 6.00%

15,324 

25,618 

7,880,450 

9,825,125 

Foreign currency

Time deposits (2)

4.41%

259,551 

421,291 

Other

11,854 

6,038 

271,405 

427,329 

8,151,855 

10,252,454 

Current

7,781,720 

9,932,774 

Non-Current

370,135 

319,680 

(1)Refers to escrow accounts, which will be released only after obtaining the applicable governmental approvals, and pending compliance by the Company with the conditions precedent in transactions involving the sale of rural properties.

(2)Refers to Time Deposit investments, with maturities over 90 days, which are remunerated bank deposits with specific maturity periods.

11 TRADE ACCOUNTS RECEIVABLE

11.1 Breakdown of balances

09/30/202612/31/2025
Domestic customers

Third parties

1,863,668 

1,918,437 

Related parties (Note 15.1) (1)

55,442 

68,209 

Foreign customers

Third parties

6,650,540 

4,705,509 

Expected credit losses (ECL)

(100,190)

(131,548)

8,469,460 

6,560,607 

(1)The balance refers to transactions with Ibema Companhia Brasileira de Papel.

33

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

The Company carries out factoring transactions for certain customer receivables where it transfers the control of all risks and rewards related to these receivables to the counterparty, so these receivables are derecognized from accounts receivable in the balance sheet. This transaction refers to an additional cash generation opportunity which can be discontinued at any time without significant impacts on the Company's operation and is therefore classified as a financial asset measured at amortized cost. The decision to assign the receivables is continuously reassessed based on market conditions and the Company's cash flow strategy, meaning that the volume of discounts may vary over time. The impact of these factoring transactions on the accounts receivable as of September 30, 2026, was R$6,672,134 (R$6,616,450 as of December 31, 2025).

11.2 Breakdown of trade accounts receivable by maturity

09/30/202612/31/2025
Current

7,291,657 

5,794,713 

Overdue

Up to 30 days

599,405 

465,967 

From 31 to 60 days

286,324 

89,398 

From 61 to 90 days

37,659 

44,305 

From 91 to 120 days

45,841 

21,225 

From 121 to 180 days

88,177 

45,072 

From 181 days

120,397 

99,927 

8,469,460 

6,560,607 

11.3 Roll-forward of expected credit losses

09/30/202612/31/2025
 Opening balance

(131,548)

(30,300)

(Provisions)/Reversals, net

23,920 

(119,417)

Write-offs

13,028 

16,937 

Acquisition of subsidiaries (Note 1.2.1)

(11,783)

Exchange rate variations

6,193 

1,232 

 Closing balance

(100,190)

(131,548)

The Company maintains guarantees for overdue receivables as part of its commercial operations, through credit insurance policies, letters of credit and other guarantees. These guarantees avoid the need to recognize expected credit losses, in accordance with the Company's credit policy.

34

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

12 INVENTORIES

09/30/202612/31/2025
Finished goods
Pulp

Domestic

952,428 

644,881 

Foreign

2,076,329 

1,713,394 

Paper and Packaging

Domestic

561,076 

423,823 

Foreign

327,626 

507,836 

Consumer Goods

Domestic

224,400 

163,393 

Foreign

1,145,268 

163 

Work in process

424,991 

113,212 

Raw materials

Wood

2,233,951 

2,267,720 

Operating supplies and packaging

1,009,460 

1,037,696 

Spare parts and other

2,147,469 

1,491,820 

Estimated losses

(277,483)

(208,091)

10,825,515 

8,155,847 

12.1 Roll-forward of estimated losses

09/30/202612/31/2025
Opening balance

(208,091)

(97,934)

(Provisions)/Reversals, net

(72,469)

(141,635)

Write-offs

37,978 

31,478 

Acquisition of subsidiaries (Note 1.2.1)

(38,481)

Exchange rate variations

3,580 

Closing balance

(277,483)

(208,091)

On September 30, 2026 and 2025, there were no inventory items pledged as collateral.

35

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

13 RECOVERABLE TAXES

09/30/202612/31/2025

Income taxes

1,224,415 

706,048 

PIS/COFINS – operations and property, plant and equipment acquisitions (1)

592,078 

696,503 

PIS/COFINS – exclusions from ICMS (2)

266,835 

324,819 

ICMS – on acquisitions of property, plant and equipment (3)

400,503 

472,382 

ICMS – operations (4)

1,987,637 

1,889,151 

Reintegra program (5)

82,736 

58,790 

Other taxes and contributions

69,216 

119,406 

Provision for loss on ICMS credits (6)

(1,804,870)

(1,775,113)

2,818,550 

2,491,986 

Current

2,004,346 

1,546,287 

Non-current

814,204 

945,699 

(1)Social Integration Program (“PIS”) and Social Security Funding Contribution (“COFINS”): Credits whose realization is based on the years of depreciation of the corresponding asset.

(2)The Company and its subsidiaries filed lawsuits over the years seeking the exclusion of ICMS from the PIS and COFINS contribution tax basis, in relation to certain transactions during various periods from March 1992.

(3)Tax on Sales and Services (“ICMS”): Credits from the acquisition of property, plant and equipment are recovered on a straight-line basis over a four-year period, from the acquisition date, in accordance with the relevant regulation, the ICMS Control on Property, Plant and Equipment (“CIAP”).

(4)ICMS credits accrued due to the volume of exports and credit generated from product import transactions: Credits are concentrated in the States of Espírito Santo, Maranhão, Mato Grosso do Sul e São Paulo, where the Company realizes the credits through the sale of credits to third parties, after approval from the State Ministry of Finance of each State. Credits are also being realized through the consumption of paper and consumer goods transactions in the domestic market.

(5)Special Regime of Tax Refunds for Export Companies ("Reintegra"): Reintegra is a program that aims to refund the residual costs of taxes paid throughout the export chain to taxpayers, to make them more competitive in foreign markets.

(6)Related to provisions for ICMS credit balances that are not probable to be recovered.

13.1 Provision for loss on ICMS credits

ICMS
09/30/202612/31/2025

Opening balance

(1,775,113)

(1,581,961)

Addition

(164,110)

(374,166)

Reversal (1)

134,353 

181,014 

Closing balance

(1,804,870)

(1,775,113)

(1)Refers mainly to the reversal of the provision for loss resulting from the recovery of ICMS credits through sale to third parties.

14 ADVANCES TO SUPPLIERS

09/30/202612/31/2025

Advances and forestry programs

3,294,943 

2,788,262 

Advances to suppliers - others

121,221 

76,818 

3,416,164 

2,865,080 

Current

121,221 

76,818 

Non-current

3,294,943 

2,788,262 

In the annual financial statements for the year ended December 31, 2025, the characteristics of the advances were disclosed, which did not change during the nine-month period ended September 30, 2026.

36

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

15 RELATED PARTIES

The Company's commercial and financial transactions with the controlling shareholder and Companies owned by the controlling shareholder Suzano Holding S.A. ("Suzano Group") were carried out in accordance with the corporate governance practices adopted by the Company, as well as those recommended and/or required by the applicable legislation.

The transactions refer mainly to:

Assets: (i) accounts receivable from the sale of Pulp, Paper and Packaging, Consumer Goods and other products; (ii) dividends receivable; (iii) reimbursement for expenses; and (iv) social services;

Liabilities: (i) loan agreements;(ii) reimbursement for expenses; (iii) social services; (iv) real estate consulting; and (v) dividends payable.

Amounts in the statements of income: (i) sale of Pulp, Paper and Packaging, Consumer Goods and other products; (ii) loan charges and exchange variation; (iii) social services and (vi) real estate consulting.

For the nine-month period ended September 30, 2026, there were no material changes in the terms of the agreements, deals and transactions entered into, nor were there any new contracts, agreements or transactions of any different nature entered into between the Company and its related parties, as disclosed in the financial statements for the year ended December 31, 2025.

37

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

15.1 Balances recognized in assets and liabilities and amounts of transactions during the year

AssetsLiabilitiesSales (purchases), net
09/30/202612/31/202509/30/202612/31/202509/30/202609/30/2025

Transactions with majority shareholders

Suzano Holding S.A.

64 

(1,718)

(412,146)

(48)

(336)

Controller

 

(893)

(219,817)

 

Related persons

 

(146)

(36,053)

 

Alden Fundo de Investimento em Ações

 

(124)

(30,444)

 

64 

(2,881)

(698,460)

(48)

(336)

Transactions with associates and joint operations

Management

576 

914 

1,775 

375 

Bexma Participações Ltda.

23 

6 

(15)

19 

11 

Naman Capital Ltda.

35 

(2)

52 

5 

Civelec Participações Ltda.

1,930 

2,895 

Fundação Arymax

22 

5 

(4)

18 

8 

Ibema Companhia Brasileira de Papel (1)

55,442 

68,209 

(2,039)

(658)

106,996 

146,503 

Instituto Ecofuturo - Futuro para o Desenvolvimento Sustentável

4 

2 

(2,474)

(3,730)

IPLF Holding S.A.

2 

(2)

3 

4 

Mabex Representações e Participações Ltda.

(953)

(16)

(3,170)

(1,022)

Nemonorte Imóveis e Participações Ltda.

(7)

(88)

(134)

Woodspin Oy

(321)

625 

58,034 

72,031 

(3,015)

(681)

102,810 

142,645 

58,098 

72,031 

(5,896)

(699,141)

102,762 

142,309 

Assets

Trade accounts receivable (Note 11)

55,442 

68,209 

Other assets

2,656 

3,822 

Liabilities

Trade accounts payable (Note 21)

(3,015)

(681)

Dividends payable

(2,837)

(698,460)

Other liabilities

(44)

58,098 

72,031 

(5,896)

(699,141)

(1)Refers mainly to the sale of pulp.

38

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

15.2 Management compensation

The amounts presented correspond to expenses related to the compensation of key management personnel, including the Board of Directors, the Fiscal Council, and the Statutory Executive Board, recognized in profit or loss on an accrual basis, encompassing the recognition and reversal of related provisions and, therefore, not necessarily reflecting the cash disbursements made during the period.

09/30/202609/30/2025

Short-term benefits

Salary or compensation

27,795 

32,767 

Direct and indirect benefits

1,119 

836 

Bonus

11,082 

20,149 

39,996 

53,752 

Long-term benefits

Share-based compensation plan

14,458 

45,658 

14,458 

45,658 

Payroll charges

Payroll charges

12,548 

32,429 

12,548 

32,429 

67,002 

131,839 

Short-term benefits include fixed compensation (salaries and fees, vacation pay, mandatory bonus and “13th month’s salary” bonus), payroll charges (Company’s share of contributions to social security – “INSS”) and variable compensation such as profit sharing, bonuses and benefits (health plan, meal voucher, market voucher, life insurance and private pension plan).

Long-term benefits include Phantom Share plans (PS), Performance Shares, and Share Appreciation Rights (SARs) granted to executives and key members of Management, in accordance with the respective plan regulations, as disclosed in Note 26.

(i) The variations are primarily attributable to a reduction in the number of executives, resulting in the recognition of termination benefits and the reversal of previously accrued short-term and long-term employee benefits.

16 INCOME AND SOCIAL CONTRIBUTION TAXES

The Company management believes in the validity of the provisions of international treaties entered by Brazil to avoid double taxation. In order to ensure its right to non-double taxation, the Company filed a lawsuit in April 2019, which aims to exempt the double taxation in Brazil, of profits earned by its subsidiary located in Austria, according to Law No. 12,973/14. Due to the preliminary injunction granted in favor of the Company in the aforementioned lawsuit, the Company decided not to add the profit from Suzano International Trade GmbH, located in Austria, when determining its taxable income and social contribution basis of the net profit of the Company for the nine-month period ended September 30, 2026. There is no provision for tax related to the non-double taxation profits of such subsidiary in 2026.

39

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

16.1 Deferred taxes

16.1.1 Deferred income and social contribution taxes

09/30/202612/31/2025

Tax loss

1,293,293 

982,480 

Negative tax basis

426,281 

381,600 

Assets - temporary differences

Provision for judicial liabilities

299,828 

269,757 

Operating provisions

593,374 

559,288 

Provisions for other losses

665,947 

619,567 

Employee benefit plans

327,414 

251,990 

Exchange rate variations

1,875,215 

3,443,822 

Business Combination - Goodwill and Fair Value Adjustments

802,887 

620,973 

Unrealized profit on inventories

304,730 

237,740 

Leases (2)

519,046 

541,431 

Tax step-up and other temporary differences in assets (1)

1,034,907 

Other Temporary Differences

226,712 

8,369,634 

7,908,648 

 Liabilities - temporary differences

Business Combination - Goodwill and Fair Value Adjustments (1)

3,954,117 

2,191,583 

Deemed cost, accelerated depreciation, and other assets

3,457,578 

2,592,333 

Fair value of biological assets

1,544,900 

1,425,535 

Tax credits

95,775 

115,003 

Derivatives gains (2)

1,822,724 

66,308 

Provision of deferred taxes on results of subsidiaries abroad

201,077 

Other temporary differences

269,558 

13,872 

11,345,729 

6,404,634 

Non-current assets

946,252 

1,504,014 

Non-current liabilities

3,922,347 

(1)It primarily relates to deferred tax effects arising from the acquisition of Arbex (Note 1.2.1), including the balances incorporated from the acquiree's opening balance sheet at the acquisition date and the deferred taxes recognized as part of the purchase price allocation (PPA) process.

(2)The Company presents a net balance of derivatives and leases, as gains and losses from deferred taxes are offset simultaneously. For the derivatives line, the taxable temporary difference was R$4,473,086 and deductible temporary difference of R$2,650,362 (taxable temporary difference was R$3,065,768 and deductible temporary difference of R$3,001,133 as of December 31, 2025). For the lease line, the taxable temporary difference was R$1,900,211 and deductible temporary difference was R$2,516,524 (taxable temporary difference was R$1,767,605 and deductible temporary difference was R$2,309,036 as of December 31, 2025).

16.1.2 Breakdown of accumulated tax losses and social contribution tax losses carried forward

09/30/202612/31/2025

Tax loss carried forward

5,283,173 

3,929,920 

Negative tax basis of social contribution carried forward

4,736,456 

4,240,000 

40

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

16.1.3 Roll-forward of deferred tax

09/30/202612/31/2025

Opening balance

1,504,014 

7,971,419 

Tax loss

310,813 

185,649 

Negative tax basis

44,681 

74,457 

Provision for judicial liabilities

30,071 

(55,116)

Operating provisions

(465,987)

12,331 

Provisions for other losses

(9,022)

72,325 

Employee benefit plans

59,970 

657 

Exchange rate variation (1)

(1,568,607)

(3,941,212)

Derivative (gains) losses (“MtM”) (1)

(1,756,416)

(2,297,143)

Business Combination - Goodwill and Fair Value Adjustments

(546,815)

(264,327)

Acquisition of subsidiaries (Note 1.2.1)

(1,033,805)

Unrealized profit on inventories

66,990 

(301,417)

Provision for Inventory Losses

(47,205)

37,179 

Leases

(22,386)

(65,513)

Deemed cost, accelerated depreciation, and other assets

(135,794)

155,673 

Fair value of biological assets

(119,365)

(108,440)

Business Combination - Goodwill and Fair Value Adjustments

872,119 

Provision of deferred taxes on results of subsidiaries abroad

(201,077)

Tax credits

19,228 

22,925 

Other temporary differences

22,498 

4,567 

Closing balance

(2,976,095)

1,504,014 

(1) Refers substantially to the effects of the appreciation of the Brazilian real against the U.S. dollar during the period, impacting the measurement of foreign currency-denominated assets and liabilities, as well as derivative instruments contracted to manage foreign exchange exposure.

41

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

16.2 Reconciliation of the effects of income tax and social contribution on profit or loss

09/30/202609/30/2025

Net income (loss) before taxes

11,919,292

20,276,673

Income tax and social contribution benefit (expense) at statutory nominal rate of 34%

(4,052,559)

(6,894,069)

Tax effect on permanent differences

Impact of the taxation difference on profit of associates in Brazil and abroad (1)

34,062

(330,497)

Equity method

(10,429)

(41,185)

Credit related to Reintegra Program

8,219

8,645

Director bonuses

(1,308)

(26,950)

Tax incentives (Note 16.3)

161,194

263,762

Other permanent exclusions

144,941

65,139

(3,715,880)

(6,955,155)

Income tax

Current

(182,605)

(368,239)

Deferred

(2,495,345)

(4,753,737)

(2,677,950)

(5,121,976)

Social Contribution

Current

(107,175)

(104,203)

Deferred

(930,755)

(1,728,976)

(1,037,930)

(1,833,179)

Income tax and social contribution result for the period

(3,715,880)

(6,955,155)

(1)The difference in the taxation of subsidiaries is substantially due to the differences between the nominal tax rates in Brazil and those of subsidiaries located abroad.

16.3 Tax incentives

The Company benefits from a tax incentive for partial reduction of the income tax obtained from operations carried out in areas under the jurisdiction of the Northeast Development Superintendence (“SUDENE”) and the Superintendence of Amazon Development (“SUDAM”). The IRPJ reduction incentive is calculated based on the activity profits (exploitation profits) and considers the allocation of the operating profit based on the incentive production levels for each product.

42

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

Area/RegionsCompanyMaturity

Northeast Development Superintendence (“SUDENE”)

Aracruz (ES)

Portocel

2030

Aracruz (ES)

Suzano

2031

Imperatriz (MA)

Suzano

2032

Mucuri (BA)

Suzano

2032

São Luís (MA)

Itacel

2033

Eunápolis (BA)

Veracel

2033

Superintendence of Amazon Development (“SUDAM”)

Belém (PA)

Suzano

2034

16.4 OECD PILLAR TWO MODEL RULES

In December 2021, the Organisation for Economic Co-operation and Development (“OECD”) announced the guidelines for the Pillar Two model, aiming for a reform in international corporate taxation to ensure that multinational economic groups, covered by such regulations, contribute an effective minimum tax at a rate of 15% on profits. Each country's effective profit tax rate, as calculated by this model, is called the GloBE (Global Anti-Base Erosion Rules) effective tax rate. In the context of Suzano, compliance with OECD guidelines on international taxation is a strategic priority.

Based on the calculations performed under the GloBE Simplifying Transition Rules (RSGT), there is no impact on the unaudited condensed consolidated interim financial information in relation to this matter.

The Company reaffirms its commitment to tax compliance and will continue to carry out the necessary actions to ensure the proper implementation of the new rule in the jurisdictions where it operates, in line with global best practices and current legislation.

16.5 Uncertainty over income tax treatments

The Company is involved in ongoing administrative and judicial proceedings concerning certain tax treatments adopted in the calculation of income taxes.

The Company assesses the likelihood that such tax treatments will be accepted by the relevant tax authorities, taking into account the applicable legislation, case law, available administrative and judicial precedents, and, when applicable, the opinions of external legal counsel. The measurement of uncertain tax positions reflects Management's best estimate of the expected outcome of these matters.

As of September 30, 2026, the total amount of uncertainties related to income taxes for which the Company considers acceptance of the adopted tax treatment by the tax authorities to be not probable amounted to R$1,858 (R$1,749 as of December 31, 2025). This amount has been fully provisioned and is presented within income tax and social contribution payable.

Additionally, as of September 30, 2026, the total amount of uncertainties related to income taxes for which the Company considers acceptance of the adopted tax treatment to be probable amounted to R$10,338,403 (R$4,559,801 as of December 31, 2025).

The main uncertainties related to income tax treatments for which acceptance is considered probable are described below:

43

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

i.Tax Assessment Notice - Foreign Earnings - Brazil-Austria Tax Treaty (2021): This matter relates to a tax assessment issued by the Brazilian Federal Revenue Service ("RFB"), received in April 2026, seeking the collection of IRPJ and CSLL in the initial amount of R$5,106,344, including interest, based on the alleged failure to tax profits earned by its subsidiary Suzano International Trade GmbH (Austria). The assessment was issued without the imposition of penalties, pursuant to a preliminary injunction granted in a writ of mandamus concerning the application of the Brazil-Austria Tax Treaty. The Company filed an administrative challenge, which is currently awaiting judgment. The estimated exposure as of September 30, 2026 amounted to R$5,255,629.

ii.Tax Assessment Notice - Exchange of Industrial and Forestry Assets (2007): This judicial action seeks to annul an administrative tax proceeding initiated by the RFB for the collection of IRPJ and CSLL based on the alleged realization of an untaxed capital gain arising from the exchange of assets with International Paper ("IP") in February 2007. In December 2012, the Company was assessed by the RFB and, in January 2016, the Administrative Council of Tax Appeals ("CARF"), by the casting vote of its President, ruled against the Company. Following notification of the decision in May 2016 and the exhaustion of administrative remedies, the Company elected to continue disputing the matter in court. The exposure is fully secured by guarantees. The court ruled in favor of the Company, and the matter is currently awaiting judgment of the appeal filed by the National Treasury. In December 2023, pursuant to Article 2 of Law No. 14,689/23, related to Article 25, Paragraph 9-A of Decree No. 70,235/72, the debt certificates were amended to definitively cancel the penalties and related charges. The estimated exposure as of September 30, 2026 amounted to R$2,039,056 (December 31, 2025: R$1,861,899), excluding the canceled penalties.

iii.Tax Assessment Notice - Non-deductible Expenses, Operating Expense Deductions, Foreign Subsidiary Earnings, Goodwill Amortization, Directors' Bonuses and Tax Loss Carryforwards (2019): This administrative proceeding was initiated in October 2023 following tax assessment notices issued against Suzano S.A. concerning fiscal year 2019. The alleged infractions relate to: (i) non-deductible expenses; (ii) improper deduction of operating expenses; (iii) profits earned abroad by a subsidiary; (iv) goodwill amortization; (v) failure to add directors' bonuses to the CSLL tax base; and (vi) tax loss carryforwards and negative CSLL basis. The Company's administrative defense was partially upheld. Subsequently, the Company filed a voluntary appeal, which was partially granted. The Company is currently awaiting formal notification of the decision. The estimated exposure as of September 30, 2026 amounted to R$1,072,144 (December 31, 2025: R$1,008,823).

iv.Tax Assessment Notice - Disallowance of Depreciation, Amortization and Depletion Expenses (2010): In December 2015, the Company was assessed for IRPJ and CSLL based on the alleged non-deductibility of depreciation, amortization and depletion expenses claimed in fiscal year 2010. The Company filed an administrative defense, which was partially upheld. The decision was appealed by the Company in November 2017. The case was converted into an evidentiary proceeding and is currently awaiting completion of the procedures ordered by CARF. The estimated exposure as of September 30, 2026 amounted to R$975,628 (December 31, 2025: R$931,979).

v.Tax Assessment Notice - Recalculation of Foreign Subsidiary Profits (2014-2016): On October 5, 2020, the Company was notified of a tax assessment issued by the RFB seeking IRPJ and CSLL arising from the recalculation of profits earned by its subsidiary Suzano Trading Ltd. during fiscal years 2014, 2015 and 2016. The Company filed an administrative challenge, which was converted into an evidentiary proceeding. Following completion of such procedures, the challenge was partially upheld. The Company subsequently appealed the unfavorable portion of the decision and is awaiting judgment. The estimated exposure as of September 30, 2026 amounted to R$704,007 (December 31, 2025: R$663,188).

44

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

17 BIOLOGICAL ASSETS

The roll-forward of biological assets is as set forth below:

09/30/202612/31/2025

Opening balance

26,097,164 

22,283,001 

Additions

5,508,253 

7,913,483 

Depletions

(5,165,606)

(5,352,271)

Transfers

15,233 

Gain on fair value adjustments (Note 7)

1,157,728 

1,516,458 

Disposals

(48,697)

(107,815)

Write-offs

(58,722)

(170,925)

Closing balance

27,490,120 

26,097,164 

The Company reevaluates, on a semi-annual basis in June and December, the main assumptions used in measuring the fair value of biological assets, which are disclosed in Note 13 of the annual financial statements for the year ended December 31, 2025.

Biological assets are measured at fair value and classified as Level 3 within the fair value hierarchy, due to the use of significant unobservable market assumptions.

The Company manages the financial and climate risks related to its agricultural activities in a preventive manner. To reduce the risks arising from edaphoclimatic factors, the weather is monitored through meteorological stations and, in the event of pests and diseases, our Department of Forestry Research and Development, an area specialized in physiological and phytosanitary aspects, has procedures to diagnose and act rapidly against any occurrences and losses (Note 4.7).

The Company has no biological assets pledged as collateral on September 30, 2026 and December 31, 2025.

45

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

18 INVESTMENTS

18.1 Investments breakdown

09/30/202612/31/2025

Investments in associates and joint ventures

229,074 

264,312 

Goodwill

29,389 

29,384 

Other investments evaluated at fair value through other comprehensive income (1)

743,848 

901,181 

1,002,311 

1,194,877 

Investments

1,002,311 

1,194,877 

1,002,311 

1,194,877 

(1) It includes the fair value measurement of Lenzing Aktiengesellschaft. As of September 30, 2026, the carrying amount of the investment was R$711,601 (R$865,986 as of December 31, 2025).

46

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

18.2 Investments in associates and joint ventures

Information of investees as at

Company Participation
09/30/2026Carrying amountIn the income (expenses) for the period
EquityIncome (expenses) of the periodParticipation equity (%)09/30/202612/31/202509/30/202609/30/2025
Associate
Foreign

Ensyn Corporation (1)

(20,213)

Spinnova Plc (2)

139,642 

(129,984)

18.75 

%

26,183 

54,391 

(24,372)

(40,714)

Simplifyber, Inc.

38,076 

(11,406)

15.52 

%

4,786 

7,973 

(2,903)

(1,407)

Allotrope Energy Ltd

2,619 

19.72 

%

516 

556 

31,485 

62,920 

(27,275)

(62,334)

Joint ventures
Domestic (Brazil)

Biomas - Serviços Ambientais, Restauração e Carbono Ltda.

15,047 

(23,631)

16.66 

%

2,507 

3,945 

(3,937)

(4,618)

Ibema Companhia Brasileira de Papel

390,946 

(4,729)

49.90 

%

195,082 

197,442 

(2,360)

13,410 

Foreign

Woodspin Oy (3)

(122,495)

197,589 

201,387 

(6,297)

(113,703)

Other investments evaluated at fair value through other comprehensive income

Bem Agro Integração e Desenvolvimento S.A.

4.58 

%

3,371 

3,581 

Celluforce Inc.

8.28 

%

23,566 

25,975 

Nfinite Nanotechnology Inc.

5.40 

%

5,310 

5,639 

Lenzing Aktiengesellschaft

15.00 

%

711,601 

865,986 

743,848 

901,181 

Goodwill (1)(3)

29,389 

29,389 

(63,634)

29,389 

29,389 

(63,634)

1,002,311 

1,194,877 

(33,572)

(239,671)

(1)In November 2025, the Company sold its entire equity interest in Ensyn Corporation, liquidated F&E Technologies LLC, and recognized impairment of the investment in F&E Tecnologia do Brasil S.A., both related to the same technology developed by Ensyn. As of December 31, 2025, as a result of this transaction, the following accounting effects were recognized, which impacted the equity pickup line: (i) R$ (160,462) related to the write-off of Ensyn goodwill; R$ 371 related to the recognition of the provision for losses on investments; and R$9,896 related to the reclassification of other comprehensive income.

(2)The average share price quoted on the Nasdaq First North Growth Market (NFNGM) was EUR0.44 on September 30, 2026 and EUR0.46 on December 31, 2025.

(3)In August 2025, the Company completed the sale of its entire equity interest in Woodspin Oy and Suzano Finland Oy to Spinnova Plc for the symbolic amount of 1 euro each. For the year ended December 31, 2025, as a result of this transaction, the following accounting effects were recognized, which significantly impacted the equity pickup line: R$ (117,447) related to the impairment of the investment, R$ (28,679) related to the obligation to make an additional capital contribution, and R$15,636 related to the realization of other comprehensive income of the joint venture Woodspin Oy; R$ (63,634) related to the write-off of goodwill of the associate Spinnova Plc; and R$ (88,871) related to the impairment of the investment in the subsidiary Suzano Finland Oy.

47

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

19 PROPERTY, PLANT AND EQUIPMENT    

LandBuildingsMachinery,
equipment and facilities
Work in progress

Other (1)

Total

Average rate %

3.44 

7.20 

19.81 

Accumulated cost

16,775,348 

13,816,631 

62,822,096 

3,510,535 

1,806,592 

98,731,202 

Accumulated depreciation

(4,294,038)

(28,541,598)

(909,526)

(33,745,162)

Balances at December 31, 2024

16,775,348 

9,522,593 

34,280,498 

3,510,535 

897,066 

64,986,040 

Additions

3,080 

262 

649,533 

3,880,270 

45,681 

4,578,826 

Write-offs

(64,222)

(54,566)

(152,457)

(154,907)

(426,152)

Depreciation

(434,875)

(4,123,031)

(287,270)

(4,845,176)

Transfers and other

5,980 

896,470 

3,524,210 

(4,626,006)

201,995 

2,649 

Accumulated cost

16,720,186 

14,589,194 

66,353,229 

2,764,799 

1,830,011 

102,257,419 

Accumulated depreciation

(4,659,310)

(32,174,476)

(1,127,446)

(37,961,232)

Balances at December 31, 2025

16,720,186 

9,929,884 

34,178,753 

2,764,799 

702,565 

64,296,187 

Additions

8,268 

248,027 

1,981,221 

1,952 

2,239,468 

Acquisition of subsidiaries (Note 1.2.1)

2,060,602 

3,294,009 

6,533,683 

532,717 

(10,496)

12,410,515 

Write-offs

(60,812)

(3,153)

(21,808)

(2,656)

(88,429)

Depreciation

(388,998)

(3,248,830)

(207,189)

(3,845,017)

Exchange rate variation, net

(5,910)

(10,367)

(27,614)

(3,092)

70 

(46,913)

Transfers and other

(1,430)

161,832 

2,618,547 

(2,933,862)

160,350 

5,437 

Accumulated cost

18,712,636 

20,028,360 

85,124,376 

2,341,783 

1,887,002 

128,094,157 

Accumulated depreciation

(7,036,885)

(44,843,618)

(1,242,406)

(53,122,909)

Balances at September 30, 2026

18,712,636 

12,991,475 

40,280,758 

2,341,783 

644,596 

74,971,248 

(1)Includes vehicles, furniture and utensils and computer equipment.

On September 30, 2026, the Company evaluated the business, market and climate impacts, and did not identify any material event that indicated the need to perform an impairment test and to record any impairment provision for property, plant and equipment.

19.1 Items pledged as collateral

On September 30, 2026, property, plant and equipment items pledged as collateral, consisting mainly of the units of Ribas do Rio Pardo, Três Lagoas and Imperatriz are set forth below:

Type of collateral9/30/202612/31/2025
Land

Financial/Legal

25,184 

25,562 
Buildings

Financial

1,682,093 

1,719,004 

Machinery, equipment and facilities (1)

Financial

8,222,799 

19,437,703 
Work in progress

Financial

389,072 

339,063 
Other

Financial

56,733 

48,475 

10,375,881 

21,569,807 

(1)The Company formalized, on January 30, 2026, the release of the fiduciary collateral over machinery and equipment associated with the Ribas do Rio Pardo pulp mill, previously pledged in favor of HSBC Corporate Trustee Company (UK) Limited, as Security Agent, and Finnish Export Credit Ltd. (FEC), in connection with the financing agreement entered into by the Company with Finnvera, totaling R$10,686,019. Following the termination of the financing agreement, the related assets were fully released from the collateral and any associated encumbrances.

48

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

19.2 Capitalized expenses

For the period ended September 30, 2026, the Company capitalized loan costs in the amount of R$50,725 (R$274,731 as of December 31, 2025). The weighted average interest rate, adjusted by the equalization of the exchange rate effects, utilized to determine the capitalized amount was 12.84% p.a. (13.35% p.a. as of December 31, 2025).

19.3 Asset Retirement Obligation (ARO)

On September 30, 2026, the Company has provisioned the amount of R$68,888 (R$68,681 as of December 31, 2025) arising asset retirement obligation of industrial landfills The corresponding liability is recorded under “Other liabilities,” segregated between current and non-current, according to the expected settlement date.

20 INTANGIBLE

20.1 Goodwill and intangible assets with indefinite useful lives

09/30/202612/31/2025

Goodwill - Arbex (Global Consumer Goods (tissue) Business) (1)

1,730,476 

Goodwill - Facepa (Tissue plant in Belém/PA)

119,332 

119,332 

Goodwill - Fibria (Pulp Mills)

7,897,051 

7,897,051 

Goodwill - MMC Brasil (Tissue plant in Mogi das Cruzes/SP)

170,859 

170,859 

Other (2)

5,100 

5,097 

9,922,818 

8,192,339 

(1)Refers to the goodwill recognized upon the acquisition of an interest in FamPro Tissue Holdings B.V. ("Arbex") (Note 1.2.1).

(2)Refers to other intangible assets with indefinite useful lives such as servitude of passage and electricity.

The goodwill is based on expected future profitability supported by valuation reports, after the purchase price allocation.

Goodwill is allocated to cash-generating units as presented in Note 5.4.

For the nine-month period ended September 30, 2026, the Company did not identify any event that indicated the need to perform the impairment test and to record any impairment provision for intangible assets.

49

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

20.2 Intangible assets with limited useful lives

09/30/202612/31/2025

Opening balance

4,778,353 

5,709,964 

Additions

452,371 

82,492 

Acquisition of subsidiaries (Note 1.2.1)

2,851,947 

Write-offs

(36)

(3,015)

Amortization

(801,843)

(1,011,088)

Exchange rate variation, net

(8,652)

Transfers and others

Closing balance

7,272,140 

4,778,353 

Represented by

Average annual rate %

Port concessions

3.94 

595,936 

621,842 

Supplier agreements

11,111 

Port service contracts

4.26 

469,076 

491,094 

Trademarks and patents (1)

4.55 

2,957,501 

154,846 

Customer portfolio

9.10 

2,668,209 

3,283,919 

Software (2)

25.45 

573,224 

206,635 

Other

10.00 

8,194 

8,906 

7,272,140 

4,778,353 

Cost

15,453,001 

12,617,166 

Amortization

(8,180,861)

(7,838,813)

Closing balance

7,272,140 

4,778,353 

(1) Variation mainly related to assets identified in the acquisition of K-C and recognized in the preliminary purchase price allocation (PPA), as described in Note 1.2.1.

(2) Variation mainly related to expenditures capitalized in connection with the implementation of SAP S/4HANA.

For the nine-month period ended September 30, 2026, the Company assessed business, market, and climate-related impacts and did not identify any material events that would indicate the need to perform an impairment test or recognize any provision related to the recoverable amount of intangible assets with definite useful lives.

21 TRADE ACCOUNTS PAYABLE

09/30/202612/31/2025

In local currency

Third party (1)

4,259,637 

4,065,115 

Related party (Note 15.1) (2)

3,015 

681 

In foreign currency

Third party (3)

4,465,489 

1,075,590 

8,728,141 

5,141,386 

(1)Within the balance of suppliers, there are values under supplier finance arrangement that were subject to anticipation with financial institutions at the exclusive option of certain suppliers, without changing the originally defined purchase conditions (payment terms and negotiated prices). The balance related to such operations on September 30, 2026 was R$418,444 (R$438,830 at December 31, 2025).

(2)The balance refers mainly to transactions with Ibema Companhia Brasileira de Papel.

(3)Refers primarily to Arbex supplier balances, acquired on July 1, 2026, which added approximately R$3.5 billion to the consolidated supplier balance. Additional information is presented in Note 1.2.1.

50

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

21.1 Long-term commitments

21.1.1 Long-term commitments - Take or Pay arrangements

During the nine-month period ended September 30, 2026, no material changes were identified in the Company’s long-term contracts with a minimum supply clause compared to the information disclosed in the financial statements for the year ended December 31, 2025 (Note 17.1.1).

21.1.2 Exchange and acquisition of biological assets

In line with the Company’s strategy for forest expansion and optimization of wood supply for its operations in the State of Mato Grosso do Sul, the Company entered into exchange and purchase agreements for biological assets in August 2025. Under the terms of these agreements, the Company receives specified volumes of biological assets between 2025 and 2027. In return, under the exchange agreement, the Company is expected to deliver equivalent volumes between 2028 and 2031.

On September 15, 2025, January 2, 2026 and July 2, 2026 payments were made in the amounts of R$878,049, R$464,156 and R$380,946 respectively. As of September 30, 2026, the remaining amount payable total R$1,142,584, due in 2028, in accordance with the contractual schedule.

51

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

22 LOANS, FINANCING AND DEBENTURES

22.1 Breakdown by type

CurrentNon-currentTotal
TypeCurrencyInterest rateAverage annual interest rate - %09/30/202612/31/202509/30/202612/31/202509/30/202612/31/2025

In foreign currency

Bonds

USD

Fixed

5.0

%

297,710 

815,478 

39,065,143 

42,405,964 

39,362,853 

43,221,442 

Panda Bonds

CNY

Fixed

2.7

%

47,232 

6,785 

2,007,306 

2,039,941 

2,054,538 

2,046,726 

Export credits (“export prepayments”)

USD

SOFR/Fixed

6.3

%

3,383,422 

923,820 

12,559,478 

16,901,305 

15,942,900 

17,825,125 

Assets financing

USD

SOFR

4.2

%

102,989 

107,159 

91,667 

178,526 

194,656 

285,685 

ECA - Export Credit Agency

USD

SOFR

7.1

%

15,230 

17,426 

1,675,670 

1,778,184 

1,690,900 

1,795,610 

IFC - International Finance Corporation (1)

USD

SOFR

6.7

%

(3,819)

(5,485)

4,862,747 

5,182,737 

4,858,928 

5,177,252 

Term bank loans

EUR

EURIBOR

3.6

%

1,434 

6,829,617 

6,831,051 

Others

3,862 

5,516 

3,862 

5,516 

3,848,060 

1,870,699 

67,091,628 

68,486,657 

70,939,688 

70,357,356 

In local currency

BNDES

BRL

UMBNDES

6.4

%

1,440 

5,794 

54,718 

468,025 

56,158 

473,819 

BNDES

BRL

TJLP

8.4

%

25,664 

89,150 

9,209 

11,802 

34,873 

100,952 

BNDES

BRL

TLP

12.3

%

238,102 

178,549 

5,665,706 

5,562,188 

5,903,808 

5,740,737 

BNDES

BRL

Fixed

4.7

%

1,666 

105,459 

107,125 

BNDES

BRL

SELIC

17.0

%

70,453 

282,017 

514,605 

70,453 

796,622 

BNDES

BRL

TR

4.3

%

10,927 

9,933 

145,533 

153,762 

156,460 

163,695 

Assets financing

BRL

CDI

16.1

%

19,146 

18,799 

23,914 

38,214 

43,060 

57,013 

NCE (“Export credit notes”)

BRL

CDI

16.6

%

28,860 

4,157 

75,000 

100,000 

103,860 

104,157 

NCR (“Rural producer certificates”)

BRL

CDI

13.7

%

44,443 

369,572 

5,563,791 

5,000,000 

5,608,234 

5,369,572 

ECO INVEST - Agro-industrial credit

BRL

CDI

11.2

%

35,532 

7,094 

456,320 

327,263 

491,852 

334,357 

Rural Product Note ("CPR")

BRL

CDI/IPCA

12.8

%

915 

41,894 

4,500,304 

1,954,437 

4,501,219 

1,996,331 

Debentures

BRL

CDI/IPCA

13.5

%

314,668 

127,247 

9,511,389 

9,179,399 

9,826,057 

9,306,646 

791,816 

1,134,206 

26,111,343 

23,309,695 

26,903,159 

24,443,901 

4,639,876 

3,004,905 

93,202,971 

91,796,352 

97,842,847 

94,801,257 

Interest on financing

1,513,287 

1,525,436 

563,791 

2,077,078 

1,525,436 

Non-current funding

3,126,589 

1,479,469 

92,639,180 

91,796,352 

95,765,769 

93,275,821 

4,639,876 

3,004,905 

93,202,971 

91,796,352 

97,842,847 

94,801,257 

(1) The balances shown as negative include fundraising costs

52

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

22.2 Breakdown by maturity - non-current

202720282029203020312032 onwards Total

In foreign currency

Bonds

2,544,910 

8,308,717 

5,123,237 

6,359,585 

16,728,694 

39,065,143 

Panda Bonds

927,240 

1,002,792 

77,274 

2,007,306 

Export credits (“export prepayments”)

776,904 

2,403,938 

3,474,846 

5,068,718 

835,072 

12,559,478 

Assets financing

23,462 

62,361 

5,844 

91,667 

ECA - Export Credit Agency

645,012 

1,030,658 

1,675,670 

IFC - International Finance Corporation (1)

1,208,877 

3,653,870 

4,862,747 

Term bank loans

6,829,617 

6,829,617 

1,727,606 

6,014,001 

11,789,407 

10,269,229 

15,878,163 

21,413,222 

67,091,628 

In local currency

BNDES – TJLP

953 

3,811 

3,811 

634 

9,209 

BNDES – TLP

40,618 

159,638 

145,472 

389,106 

491,754 

4,439,118 

5,665,706 

BNDES – Fixed

781 

3,124 

6,528 

6,837 

6,837 

81,352 

105,459 

BNDES – TR

2,758 

11,033 

11,033 

11,033 

11,033 

98,643 

145,533 

BNDES - UMBNDES

371 

3,215 

3,215 

3,215 

3,215 

41,487 

54,718 

ECO INVEST - Agro-industrial credit

8,577 

17,153 

90,771 

90,771 

90,771 

158,277 

456,320 

Assets financing

4,814 

19,033 

67 

23,914 

NCE (“Export credit notes”)

25,000 

25,000 

25,000 

75,000 

Rural Product Note ("CPR")

4,500,304 

4,500,304 

NCR (“Rural producer certificates”)

2,000,000 

3,563,791 

5,563,791 

Debentures

572,611 

500,000 

8,438,778 

9,511,389 

58,872 

242,007 

285,897 

3,099,207 

4,667,401 

17,757,959 

26,111,343 

1,786,478 

6,256,008 

12,075,304 

13,368,436 

20,545,564 

39,171,181 

93,202,971 

(1) Amendment to the payment schedule as a result of a contractual amendment executed in June 2026, extending the maturity date and reducing the interest rate.

22.3 Roll-forward of loans, financing and debentures

09/30/202612/31/2025

Opening balance

94,801,257 

101,435,531 

Fundraising, net of issuance costs

3,087,472 

23,871,760 

Additions of merged companies

6,904,000 

Interest accrued

4,414,775 

5,953,778 

Monetary and exchange rate variation, net

(3,606,818)

(8,384,101)

Settlement of principal

(3,385,149)

(22,353,325)

Settlement of interest

(4,447,630)

(5,817,907)

Amortization of fundraising costs

74,940 

101,803 

Others

(6,282)

Closing balance

97,842,847 

94,801,257 

53

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

22.4 Fundraising costs

The fundraising costs are amortized based on the terms of agreements and the effective interest rate.

Balance to be amortized
TypeCostAmortization09/30/202612/31/2025

Bonds

411,818 

294,543 

117,275 

142,598 

Panda Bonds

6,183 

2,261 

3,922 

5,617 

Rural Product Note ("CPR")

144,391 

8,760 

135,631 

63,819 

Export credits (“export prepayments”)

180,466 

130,099 

50,367 

71,612 

Debentures

157,139 

54,965 

102,174 

110,409 

BNDES

80,363 

54,262 

26,101 

41,023 

ECA - Export Credit Agency

13,615 

3,627 

9,988 

12,072 

IFC - International Finance Corporation

106,968 

37,475 

69,493 

57,186 

Term bank loans

45,172 

2,093 

43,079 

Others

4,797 

570 

4,227 

4,641 

1,150,912 

588,655 

562,257 

508,977 

22.5 Guarantees

Some loan and financing agreements have guarantees clauses, in which the financed equipment or other property, plant and equipment is offered as collateral by the Company, as disclosed in Note 19.1.

The Company is subject to financial covenants in connection with the Term Bank Loans disclosed in Note 22.1, which had an outstanding balance of R$6,831,051 as of September 30, 2026. These covenants require the Company to maintain a Net Debt-to-EBITDA ratio not exceeding 4.0x, as defined in the respective financing agreement. Compliance with such covenant is monitored on a quarterly basis by Management and was fully achieved as of September 30, 2026.

22.6 Relevant transactions entered into during the period

22.6.1 New Revolving Credit Facility (RCF)

On February 5, 2026, the Company entered into a new Revolving Credit Facility through its subsidiary Suzano International Finance B.V., replacing the facility in place since February 2022. The new facility increased the total available revolving credit lines from US$1,275,000 to US$1,775,000 (equivalent to R$9,196,097). The purpose of this new facility is to further strengthen the Company’s already robust liquidity position, providing greater cash flexibility over the coming years.

The total committed amount of US$1,775,000 has an availability period through February 2031. The commitment fee, if the facility remains undrawn, is 0.27% per annum; if drawn, the cost will be SOFR + 0.90% per annum.

22.6.2 Issuance of Rural Product Notes (Cédulas de Produto Rural – CPRs)

On April 1, 2026, the Company completed the fundraising of its 2nd issuance of Financial Settlement Rural Product Notes (CPR-Fs), issued in two tranches totaling R$2,500,000, of which R$1,500,000 relate to the first tranche and R$1,000,000 to the second tranche.

The CPR-Fs were issued on March 15, 2026, with maturities of 10 years for the first tranche, due on March 15, 2036, and 12 years for the second tranche, due on March 15, 2038. The CPR-Fs bear interest of 7.0464% per annum for the first tranche and 6.8338% per annum for the second tranche, accruing on the updated nominal unit value, which is adjusted by the accumulated variation of the IPCA inflation index.

54

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

22.7 Significant transactions settled during the period

The Company did not enter into any material settlements during the nine-month period ended September 30, 2026.

23 LEASES

23.1 Right of use

The balances rolled-forward are set out below:

 Lands Machinery and equipment BuildingsShips and boatsVehicles Total

Balances at December 31, 2024

3,475,569 

175,043 

114,392 

1,373,338 

42,349 

5,180,691 

Additions/updates

618,637 

212,173 

135,659 

10,765 

977,234 

Depreciation (1)

(441,499)

(200,883)

(58,630)

(122,833)

(1,622)

(825,467)

Write-offs (2)

(327)

(277)

(65)

(669)

Balances at December 31, 2025

3,652,380 

186,056 

191,356 

1,261,270 

40,727 

5,331,789 

Additions/updates

201,916 

118,361 

170,606 

299 

10,989 

502,171 

Acquisition of subsidiaries (Note 1.2.1)

52,876 

270,683 

60,830 

384,389 

Depreciation (1)

(334,901)

(115,788)

(76,507)

(90,635)

(8,350)

(626,181)

Exchange rate variation, net

913 

(2,489)

(1,737)

(3,313)

Balances at September 30, 2026

3,519,395 

242,418 

553,649 

1,170,934 

102,459 

5,588,855 

(1)The amount of depreciation related to land is substantially reclassified to biological assets to make up the formation costs.

(2)Write-off due to cancellation of contracts.

On September 30, 2026, the Company does not have commitments to lease agreements not yet in force.

23.2 Lease liabilities

The balance of lease payables on September 30, 2026, measured at present value and discounted at the respective discount rates are set forth below:

Nature of agreement

Average rate - % p.a. (1)

Maturity (2)

Present value of liabilities

Lands and farms

12.77

%

September/2053

4,108,603 

Machinery and equipment

11.60

%

April/2035

357,594 

Buildings

8.23

%

February/2035

570,231 

Ships and boats

12.20

%

February/2039

2,015,751 

Vehicles

4.51

%

November/2028

75,068 

7,127,247 

(1)For the determination of the discount rates, the market CDI rate obtained from the yield curve on B3’s official website was used, considering the term equivalent to the final maturity and the nature of the contracts.

(2)Refers to the original maturities of the agreements and, therefore, does not consider eventual renewal clauses.

55

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

The balances rolled-forward are set out below:

09/30/202612/31/2025

Opening balance

6,929,890 

6,972,915 

Additions/updates

502,171 

977,234 

Acquisition of subsidiaries (Note 1.2.1)

384,402 

Write-offs

(669)

Payments

(1,080,282)

(1,447,973)

Accrual of financial charges (1)

535,392 

733,342 

Exchange rate variations

(144,326)

(304,959)

Closing balance

7,127,247 

6,929,890 

Current

971,565 

857,810 

Non-current

6,155,682 

6,072,080 

(1)On September 30, 2026, the amount of R$201,609 related to interest expenses on leased lands was capitalized to biological assets to represent the formation cost (R$265,463 as of December 31, 2025).

The maturity schedule for future payments not discounted to present value related to lease liabilities is disclosed in Note 4.2.

23.2.1 Amounts recognized in the statement of income for the period

The amounts presented relate to contracts that qualify for the exemptions established in the Company's accounting policy for short-term and low-value contracts. In these cases, the related assets and liabilities are not recognized, and the associated expenses are recognized directly in statement of income as incurred.

Expenses recognized in statement of income amounted to R$1,965 (R$2,476 as of September 30, 2025).

24 PROVISION FOR JUDICIAL LIABILITIES

The Company is involved in certain legal proceedings arising in the normal course of its business, which include tax, social security, labor, civil, environment and real estate.

The Company classifies the risk of unfavorable decisions in legal proceedings, based on legal advice, which reflects the estimated probable losses.

The Company’s Management believes that, based on the available information as of the date of these unaudited condensed consolidated interim financial information, its provisions for tax, social security, labor, civil, environment and real estate risks, accounted for according to IAS 37 are sufficient to cover estimated losses related to its legal proceedings, as set forth below:

56

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

24.1 Roll-forward and changes in the provisions for probable losses based on the nature of the proceedings, net of judicial deposits

09/30/2026
Tax and
social security
LaborCivil, environment and real estate

Contingent liabilities assumed (1) (2)

Total

Provision balance at the beginning of the period

339,763 

296,358 

185,411 

2,095,357 

2,916,889 

Payments

(4,002)

(32,390)

(18,942)

(55,334)

Provisions/(Reversals), net

(5,818)

39,726 

32,860 

(70,331)

(3,563)

Monetary and exchange rate variation, net

18,792 

16,228 

17,795 

52,815 

Provision balance

348,735 

319,922 

217,124 

2,025,026 

2,910,807 

Judicial deposits (3)

(32,912)

(60,622)

(63,525)

(157,059)

Provision balance at the end of the period

315,823 

259,300 

153,599 

2,025,026 

2,753,748 

(1)Amounts arising from tax-related lawsuits with a possible or remote probability of loss in the amount of R$1,898,989 and civil lawsuits in the amount of R$126,037, measured and recorded at the estimated fair value resulting from the business combination with Fibria.

(2)Reversal due to a change in likelihood, cancellation and/or due to settlement.

(3)The amounts presented refer exclusively to judicial deposits for which there is a legally enforceable right of offset.

12/31/2025
Tax and
social security
LaborCivil, environment and real estate

Contingent liabilities assumed (1) (2)

Total

Provision balance at the beginning of the period

407,964 

353,926 

215,553 

2,127,725 

3,105,168 

Payments

(71,692)

(113,840)

(9,176)

(194,708)

Provisions/(Reversals), net

(36,578)

28,281 

(41,457)

(32,368)

(82,122)

Monetary and exchange rate variation, net

40,069 

27,991 

20,491 

88,551 

Provision balance

339,763 

296,358 

185,411 

2,095,357 

2,916,889 

Judicial deposits (3)

(31,579)

(62,334)

(21,238)

(115,151)

Provision balance at the end of the period

308,184 

234,024 

164,173 

2,095,357 

2,801,738 

(1)Amounts arising from tax-related lawsuits with a possible or remote probability of loss in the amount of R$1,962,549 and civil lawsuits in the amount of R$132,808, measured and recorded at the estimated fair value resulting from the business combination with Fibria.

(2)Reversal due to a change in likelihood, cancellation and/or due to settlement.

(3)The amounts presented refer exclusively to judicial deposits that have a legal right of offset.

24.1.1 Tax and social security

On September 30, 2026, the Company has 47 (56 as of December 31, 2025) administrative and judicial proceedings of a tax or social security nature in which the disputed matters are related to IRPJ, CSLL, PIS, COFINS, ICMS among others, whose amounts are provisioned when the likelihood of loss is deemed probable by the Company’s external legal counsel and by Management.

From these, 1 proceeding, amounting to a total of R$1,858 (R$1,749 as of December 31, 2025), relate to matters involving income taxes and, in accordance with IFRIC 23 – Uncertainty over Income Tax Treatments, are recognized under income tax and social contribution payable (Note 16.5).

24.1.2 Labor

On September 30, 2026, the Company has 1,147 (1,152 as of December 31, 2025) labor lawsuits.

In general, the provisioned labor proceedings are related primarily to matters frequently contested by employees of agribusiness companies, such as wages and/or severance payments, in addition to suits filed by outsourced employees of the Company.

57

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

24.1.3 Civil, environment and real estate

On September 30, 2026, the Company has 96 (73 as at December 31, 2025) civil, environmental and real estate proceedings.

The provisioned Civil, environment and real estate proceedings are related primarily to the payment of damages, including those arising from contractual obligations, traffic-related injuries, possessory actions, environmental restoration obligations, claims and others.

24.2 Contingencies with possible losses

The Company is involved in tax, civil and labor lawsuits, whose losses have been assessed as possible by Management, supported by legal counsel, and therefore no provision was recorded:

09/30/202612/31/2025

Taxes and social security (1) - Income taxes (2)(3)

10,338,403 

4,559,801 

Taxes and social security (1) - Other taxes and contributions (4)

7,257,343 

5,857,933 

Labor

220,448 

189,506 

Civil and environmental (1)

1,143,009 

1,023,689 

18,959,203 

11,630,929 

(1)The amounts above do not include the fair value adjustments allocated to possible loss risk contingencies representing R$2,009,759 (R$2,076,296 as of December 31, 2025), which were recorded at fair value resulting from business combinations with Fibria, as presented in Note 24.1.1 above.

(2)In April 2026, the Company received a Notice of Assessment related to the taxation of profits earned by its subsidiary in Austria, with an estimated exposure of R$5,255,629 as of September 30, 2026. In the Company's opinion, supported by the opinions of its external legal advisors, the likelihood of loss is assessed as possible.

(3)The Company is involved in administrative and judicial disputes with the tax authorities related to tax positions adopted in the determination of corporate income tax and social contribution on net income (IRPJ/CSLL). Based on the current assessment, these positions are expected to be upheld in final rulings by higher courts. A summary of these matters under dispute and their potential effects is presented in Note 16.5.

(4)Based on the assessment of Company's legal advisors and considering the procedural developments, the loss prognosis of certain administrative proceedings related to PIS and COFINS tax credits, in the approximate amount of R$1,124,383, which were reclassified as possible loss, with no final decision regarding the merits of the disputes.

In the nine-month period ended September 30, 2026, there were no significant changes in the main natures of these contingencies compared to those disclosed in the annual financial statements for the year ended December 31, 2025 (Note 24.1), except for the IRPJ and CSLL Tax Assessment Notice received in April 2026, which is described in Item 16.5 (i) of these financial statements.

25 EMPLOYEE BENEFIT PLANS

The Company provides supplementary pension plan and defined benefit plan, such as medical assistance and life insurance. The characteristics of such benefits were disclosed in the annual financial statements for the year ended December 31, 2025 (Note 25), and no significant changes occurred during the nine-month period ended September 30, 2026.

25.1 Pension plan

Contributions made by the Company, for Suzano Prev pension plan managed by Brasilprev Seguros e Previdência S.A., for the nine-month period ended September 30, 2026 amounted R$17,938 (R$18,077 as of September 30, 2025) recognized under the cost of sales, selling and general and administrative expenses.

25.2 Defined benefits plan

The Company offers the medical assistance and life insurance in addition to the pension plans, which are measured based on actuarial calculations and recognized in the unaudited condensed consolidated interim financial information.

58

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

The roll-forward of actuarial liabilities prepared based on actuarial report is set forth below:

09/30/202612/31/2025

Opening balance

741,143 

721,560 

Interest on actuarial liabilities

58,958 

77,348 

Current service cost

3,141 

1,939 

Actuarial gain – experience (1)

(13,340)

Actuarial loss – financial assumptions (1)

6,026 

Benefits paid directly by entity

(41,076)

(52,390)

Acquisition of subsidiaries (Note 1.2.1)

124,391 

Exchange rate variation, net

(1,120)

Closing balance

885,437 

741,143 

(1)Actuarial gains and losses are determined annually based on an independent actuarial valuation, reflecting changes in actuarial assumptions and experience adjustments arising from the measurement of defined benefit obligations.

26 SHARE-BASED COMPENSATION PLAN

The Company has long-term share-based remuneration plans: (i) Phantom stock option plan (“PS”), settled in cash; and (ii) Performance Share Plan, settled in shares.

The characteristics and measurement method of each plan were disclosed in the annual financial statements for the year ended December 31, 2025 (Note 22), which did not change during the nine-month period ended September 30, 2026.

26.1 Phantom shares plan

The roll-forward arrangements are set out below:

Number of shares
Year of grantFair value on grant date31/12/2025Shares grantedCancelled

Exercised (1)

30/09/2026Available for completionYear of vesting
2026202720282029

2021

R$64.12 

7,735 

168 

(7,903)

2022

R$54.20 

480,184 

10,447 

(221)

(353,216)

137,194 

65,308 

47,391 

24,495 

2023

R$48.81 

2,695,561 

58,994 

(55,204)

(814,060)

1,885,291 

1,652,646 

232,645 

2024

R$56.58 

2,459,390 

53,332 

(197,838)

(37,859)

2,277,025 

2,121,150 

155,875 

2025

R$59.65 

3,410,537 

148,358 

(258,559)

(43,895)

3,256,441 

3,256,441 

2026

R$51.58 

2,700,208 

(93,640)

(10,038)

2,596,530 

2,596,530 

Number of stock options

9,053,407 

2,971,507 

(605,462)

(1,266,971)

10,152,481 

65,308 

1,700,037 

2,378,290 

3,412,316 

2,596,530 

Book value

332,322 

89,210 

(5,134)

(65,455)

350,943 

Book value of the previous year

361,974 

209,842 

(17,843)

(221,651)

332,322 

(1)The average price of the share options exercised and exercised due to termination of employment from July 1 to September 30, 2026 was R$50.35.

59

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

26.2 Restricted shares plan

The position is set forth below:

Number of stock options
Year of grantFair value on grant date31/12/2025Shares grantedExercised/Cancelled30/09/2026Year of vesting
20272028202920302031

2023

R$50.51 

277,249 

6,033 

(283,282)

2024

R$56.09 

2,331,602 

50,731 

(443,635)

1,938,698 

440,715 

1,497,983 

2025

R$60.47 

467,265 

10,166 

477,431 

235,794 

241,637 

2026

R$51.09 

465,844 

465,844 

273,277 

192,567 

Number of stock options

3,076,116 

532,774 

(726,917)

2,881,973 

440,715 

235,794 

1,771,260 

241,637 

192,567 

Book value

80,742 

27,949 

(27,031)

81,660 

Book value of the previous year

60,226 

45,642 

(25,126)

80,742 

27 SHAREHOLDERS’ EQUITY

27.1 Share capital

On September 30, 2026, Suzano recorded a capital increase of R$14,574, bringing its share capital to R$24,283,855 divided into 1,264,117,615 common shares, all nominative, book-entry shares without par value. Expenses related to the public offering were R$33,735, totaling a net share capital of R$24,250,120. The breakdown of the share capital is as set out below:

09/30/202612/31/2025
Quantity(%)Quantity(%)

Controlling Shareholders

Suzano Holding S.A.

358,840,106 

28.39 

367,612,329

29.08 

Controller

197,107,606 

15.59 

196,065,636

15.51 

Related persons

34,377,592 

2.72 

26,568,442

2.10 

Alden Fundo de Investimento em Ações

27,154,744 

2.15 

27,154,744

2.15 

617,480,048 

48.85 

617,401,151

48.84 

Treasury (Note 27.2)

32,556,893 

2.58 

28,208,827

2.23 

Other shareholders

614,080,674 

48.57 

618,507,637

48.93 

1,264,117,615 

100.00 

1,264,117,615

100.00 

On September 30, 2026, SUZB3 common shares ended the period quoted at R$44.20 and R$51.45 on December 31, 2025.

27.2 Treasury shares

On September 30, 2026, the Company had 32,556,893 (28,208,827 as of December 31, 2025) of its own common shares held in treasury, with an average cost of R$51.92 per share, with a historical value of R$1,690,481 (R$1,511,146 as at December 31, 2025) and the market corresponding to R$1,439,015 (R$1,451,344 as at December 31, 2025).

60

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


Suzano S.A.

Capturar.jpg

Notes to the unaudited condensed consolidated interim financial information
Nine-month period ended September 30, 2026
(In thousands of R$, unless otherwise stated)

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg

For the nine-month period ended September 30, 2026, the Company granted 356,734 common shares at an average cost of R$53.57 per share, with a historical value of R$19,110, to comply with the restricted shares plan (Note 26.2).

Quantity Average cost
per share
Historical
value
Market
value

Balances at December 31, 2024

24,875,787 

53.84 

1,339,197 

1,536,826 

Exercised

(372,160)

53.66 

(19,969)

(20,251)

Repurchase

3,705,200 

51.80 

191,918 

191,918 

Balances at December 31, 2025

28,208,827 

53.57 

1,511,146 

1,451,344 

Exercised

(356,734)

53.57 

(19,110)

(18,383)

Repurchase

4,704,800 

42.18 

198,445 

198,445 

Balances at September 30, 2026

32,556,893 

51.92 

1,690,481 

1,439,015 

28 EARNINGS PER SHARE

28.1 Basic

The basic earnings per share is measured by dividing the profit attributable to the Company’s shareholders by the weighted average number of common shares issued during the period, excluding the common shares acquired by the Company and held as treasury shares.

09/30/202609/30/2025

Net income for the period attributed to Controlling shareholders'

8,209,902 

13,298,971 

Weighted average number of shares in the period – in thousands

1,264,118 

1,264,118 

Weighted average treasury shares – in thousands

(29,953)

(27,149)

Weighted average number of outstanding shares – in thousands

1,234,165 

1,236,969 

Basic earnings per common share – R$

6.65219 

10.75126 

28.2 Diluted

The diluted earnings per share is measured by adjusting the weighted average of outstanding common shares, assuming the conversion of all common shares with dilutive effects.

09/30/202609/30/2025

Net income for the period attributed to Controlling shareholders'

8,209,902 

13,298,971 

Weighted average number of outstanding shares – in thousands

1,234,165 

1,236,969 

Average number of potential shares (stock options) - in thousands

2,841 

3,076 

Weighted average number of shares (diluted) – in thousands

1,237,006 

1,240,045 

Diluted earnings per common share – R$

6.63691 

10.72459 

61

Suzano-Selo100anos-principal-en-cmyk.ai (4).jpg


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 5, 2026

SUZANO S.A.

By:

/s/ Marcos Moreno Chagas Assumpção

Name:

Marcos Moreno Chagas Assumpção

Title:

Chief Financial and Investor Relations Officer

View source ↗ · 中文页面